Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix structural constituent	COL8A2 FN1 LAMA1 LAMA2 ZP1 COL18A1 THBS1 FBN1 NID1 LTBP4 MUC5AC FBN3	1.76e-08	188	149	12	GO:0005201
GeneOntologyMolecularFunction	collagen binding	FN1 MAP1A THBS1 COCH MRC2 TLL1 NID1	2.45e-06	81	149	7	GO:0005518
GeneOntologyMolecularFunction	lipoprotein particle binding	ABCA1 STAB2 STAB1 THBS1 LPL	5.86e-06	35	149	5	GO:0071813
GeneOntologyMolecularFunction	protein-lipid complex binding	ABCA1 STAB2 STAB1 THBS1 LPL	5.86e-06	35	149	5	GO:0071814
GeneOntologyMolecularFunction	calcium ion binding	STAB2 PAMR1 ITLN1 FAT3 CUBN PPEF2 STAB1 THBS1 FBN1 SCUBE2 TLL1 LPL NID1 EDEM1 FER1L5 LTBP4 FBN3 NOTCH1	1.24e-05	749	149	18	GO:0005509
GeneOntologyMolecularFunction	glycosaminoglycan binding	STAB2 FN1 RSPO4 PTCH1 STAB1 THBS1 FBN1 LPL ELANE LTBP4	3.41e-05	268	149	10	GO:0005539
GeneOntologyMolecularFunction	ribonucleoside binding	POLR2B POLR3B	1.65e-04	3	149	2	GO:0032549
GeneOntologyMolecularFunction	low-density lipoprotein particle binding	STAB2 STAB1 THBS1	3.06e-04	18	149	3	GO:0030169
GeneOntologyMolecularFunction	alpha-sialidase activity	NEU4 NEU2	3.29e-04	4	149	2	GO:0016997
GeneOntologyMolecularFunction	exo-alpha-sialidase activity	NEU4 NEU2	3.29e-04	4	149	2	GO:0004308
GeneOntologyMolecularFunction	hedgehog family protein binding	PTCH1 SCUBE2	3.29e-04	4	149	2	GO:0097108
GeneOntologyMolecularFunction	apolipoprotein binding	ABCA1 LCAT LPL	4.23e-04	20	149	3	GO:0034185
GeneOntologyMolecularFunction	apolipoprotein A-I binding	ABCA1 LCAT	5.45e-04	5	149	2	GO:0034186
GeneOntologyMolecularFunction	proteoglycan binding	FN1 THBS1 LPL NID1	5.67e-04	51	149	4	GO:0043394
GeneOntologyMolecularFunction	heparin binding	FN1 RSPO4 PTCH1 THBS1 FBN1 LPL ELANE	6.06e-04	192	149	7	GO:0008201
GeneOntologyMolecularFunction	cholesterol binding	ABCA1 PTCH1 OSBPL3 OSBPL7	9.24e-04	58	149	4	GO:0015485
GeneOntologyMolecularFunction	polyubiquitin modification-dependent protein binding	HDAC6 BABAM2 OTUD7B AGL	9.85e-04	59	149	4	GO:0031593
GeneOntologyMolecularFunction	hydrolase activity, hydrolyzing O-glycosyl compounds	NEU4 MAN2B1 NEU2 AGL EDEM1	1.05e-03	103	149	5	GO:0004553
GeneOntologyMolecularFunction	endopeptidase activity	PAMR1 ADAM23 MMP27 KLK12 CASP9 ADAM22 MST1 TLL1 ELANE KLKB1	1.48e-03	430	149	10	GO:0004175
GeneOntologyBiologicalProcess	positive regulation of integrin-mediated signaling pathway	FLNA LAMA1 LAMA2 NID1	2.35e-06	14	147	4	GO:2001046
GeneOntologyBiologicalProcess	extracellular matrix organization	MYF5 COL8A2 FN1 LAMA1 MMP27 LAMA2 COL18A1 TLL1 ELANE NID1 LTBP4 NOTCH1	1.71e-05	377	147	12	GO:0030198
GeneOntologyBiologicalProcess	extracellular structure organization	MYF5 COL8A2 FN1 LAMA1 MMP27 LAMA2 COL18A1 TLL1 ELANE NID1 LTBP4 NOTCH1	1.76e-05	378	147	12	GO:0043062
GeneOntologyBiologicalProcess	external encapsulating structure organization	MYF5 COL8A2 FN1 LAMA1 MMP27 LAMA2 COL18A1 TLL1 ELANE NID1 LTBP4 NOTCH1	1.80e-05	379	147	12	GO:0045229
GeneOntologyBiologicalProcess	regulation of integrin-mediated signaling pathway	FLNA LAMA1 LAMA2 NID1	1.97e-05	23	147	4	GO:2001044
GeneOntologyBiologicalProcess	regulation of basement membrane organization	LAMA1 LAMA2 NID1	5.61e-05	11	147	3	GO:0110011
GeneOntologyBiologicalProcess	pro-B cell differentiation	SOX4 LIG4 NOTCH1	9.63e-05	13	147	3	GO:0002328
GeneOntologyBiologicalProcess	positive regulation of muscle cell differentiation	MYF5 LAMA1 LAMA2 NEU2 NID1 NOTCH1	1.12e-04	106	147	6	GO:0051149
GeneOntologyCellularComponent	extracellular matrix	COL8A2 FN1 ITLN1 LAMA1 MMP27 LAMA2 ZP1 MST1 COL18A1 THBS1 FBN1 FCGBP COCH ELANE NID1 LTBP4 MUC5AC HCFC1 FBN3	2.27e-07	656	149	19	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	COL8A2 FN1 ITLN1 LAMA1 MMP27 LAMA2 ZP1 MST1 COL18A1 THBS1 FBN1 FCGBP COCH ELANE NID1 LTBP4 MUC5AC HCFC1 FBN3	2.37e-07	658	149	19	GO:0030312
GeneOntologyCellularComponent	collagen-containing extracellular matrix	COL8A2 FN1 ITLN1 LAMA1 LAMA2 ZP1 MST1 COL18A1 THBS1 FBN1 COCH ELANE NID1 LTBP4 HCFC1	6.10e-06	530	149	15	GO:0062023
GeneOntologyCellularComponent	basement membrane	COL8A2 FN1 LAMA1 LAMA2 COL18A1 FBN1 NID1	2.74e-05	122	149	7	GO:0005604
GeneOntologyCellularComponent	microfibril	FBN1 LTBP4 FBN3	9.63e-05	13	149	3	GO:0001527
GeneOntologyCellularComponent	brush border	FLNA RALGDS MYO1A MYO7B ITLN1 CUBN PTH1R	1.11e-04	152	149	7	GO:0005903
GeneOntologyCellularComponent	protein complex involved in cell-matrix adhesion	LAMA1 LAMA2 NID1	2.24e-04	17	149	3	GO:0098637
GeneOntologyCellularComponent	cluster of actin-based cell projections	FLNA RALGDS MYO1A MYO7B ITLN1 CUBN PTH1R	1.12e-03	223	149	7	GO:0098862
Domain	EGF	STAB2 PAMR1 ADAM23 FAT3 LAMA1 LAMA2 CUBN ADAM22 STAB1 THBS1 FBN1 FCGBP SCUBE2 TLL1 NID1 LTBP4 FBN3 NOTCH1	4.19e-13	235	147	18	SM00181
Domain	EGF-like_dom	STAB2 PAMR1 ADAM23 FAT3 LAMA1 LAMA2 CUBN ADAM22 STAB1 THBS1 FBN1 FCGBP SCUBE2 TLL1 NID1 LTBP4 FBN3 NOTCH1	1.12e-12	249	147	18	IPR000742
Domain	EGF_1	STAB2 FN1 PAMR1 ADAM23 FAT3 LAMA1 LAMA2 CUBN ADAM22 STAB1 THBS1 FBN1 SCUBE2 TLL1 NID1 LTBP4 FBN3 NOTCH1	1.68e-12	255	147	18	PS00022
Domain	EGF-like_CS	STAB2 FN1 PAMR1 ADAM23 FAT3 LAMA1 LAMA2 CUBN ADAM22 STAB1 THBS1 FBN1 SCUBE2 TLL1 NID1 LTBP4 FBN3 NOTCH1	2.50e-12	261	147	18	IPR013032
Domain	EGF_CA	STAB2 PAMR1 FAT3 CUBN STAB1 THBS1 FBN1 SCUBE2 TLL1 NID1 LTBP4 FBN3 NOTCH1	1.37e-11	122	147	13	SM00179
Domain	EGF-like_Ca-bd_dom	STAB2 PAMR1 FAT3 CUBN STAB1 THBS1 FBN1 SCUBE2 TLL1 NID1 LTBP4 FBN3 NOTCH1	1.69e-11	124	147	13	IPR001881
Domain	EGF_2	STAB2 PAMR1 ADAM23 FAT3 LAMA1 LAMA2 CUBN ADAM22 STAB1 THBS1 FBN1 SCUBE2 TLL1 NID1 LTBP4 FBN3 NOTCH1	3.32e-11	265	147	17	PS01186
Domain	Growth_fac_rcpt_	STAB2 CRIM1 LAMA1 RSPO4 CUBN STAB1 FBN1 IGFBP1 SCUBE2 NID1 LTBP4 FBN3 NOTCH1	3.09e-10	156	147	13	IPR009030
Domain	EGF_3	STAB2 PAMR1 ADAM23 FAT3 CUBN ADAM22 STAB1 THBS1 FBN1 SCUBE2 TLL1 NID1 LTBP4 FBN3 NOTCH1	5.44e-10	235	147	15	PS50026
Domain	EGF_CA	FAT3 CUBN THBS1 FBN1 SCUBE2 TLL1 NID1 LTBP4 FBN3 NOTCH1	1.42e-09	86	147	10	PF07645
Domain	CUB	KREMEN1 PAMR1 CUBN CSMD2 CSMD3 SCUBE2 NETO2 TLL1	4.17e-09	49	147	8	PF00431
Domain	CUB	KREMEN1 PAMR1 CUBN CSMD2 CSMD3 SCUBE2 NETO2 TLL1	4.94e-09	50	147	8	SM00042
Domain	-	KREMEN1 PAMR1 CUBN CSMD2 CSMD3 SCUBE2 NETO2 TLL1	6.83e-09	52	147	8	2.60.120.290
Domain	CUB	KREMEN1 PAMR1 CUBN CSMD2 CSMD3 SCUBE2 NETO2 TLL1	7.99e-09	53	147	8	PS01180
Domain	CUB_dom	KREMEN1 PAMR1 CUBN CSMD2 CSMD3 SCUBE2 NETO2 TLL1	1.45e-08	57	147	8	IPR000859
Domain	EGF_dom	STAB2 CUBN STAB1 SCUBE2 NID1	2.14e-08	12	147	5	IPR024731
Domain	EGF_3	STAB2 CUBN STAB1 SCUBE2 NID1	2.14e-08	12	147	5	PF12947
Domain	EGF_Ca-bd_CS	FAT3 CUBN FBN1 SCUBE2 TLL1 NID1 LTBP4 FBN3 NOTCH1	7.19e-08	97	147	9	IPR018097
Domain	EGF_CA	FAT3 CUBN FBN1 SCUBE2 TLL1 NID1 LTBP4 FBN3 NOTCH1	8.59e-08	99	147	9	PS01187
Domain	EGF-type_Asp/Asn_hydroxyl_site	FAT3 CUBN FBN1 SCUBE2 TLL1 NID1 LTBP4 FBN3 NOTCH1	1.56e-07	106	147	9	IPR000152
Domain	EGF	STAB2 PAMR1 CUBN STAB1 SCUBE2 TLL1 NID1 FBN3 NOTCH1	6.83e-07	126	147	9	PF00008
Domain	ASX_HYDROXYL	FAT3 CUBN FBN1 SCUBE2 NID1 LTBP4 FBN3 NOTCH1	1.23e-06	100	147	8	PS00010
Domain	VWC	CRIM1 MUC19 THBS1 FCGBP MUC5AC	1.15e-05	38	147	5	SM00214
Domain	VWC_out	CRIM1 MUC19 FCGBP MUC5AC	1.30e-05	19	147	4	SM00215
Domain	TB	FBN1 LTBP4 FBN3	1.63e-05	7	147	3	PF00683
Domain	VWF_dom	CRIM1 MUC19 THBS1 FCGBP MUC5AC	1.90e-05	42	147	5	IPR001007
Domain	-	FBN1 LTBP4 FBN3	2.60e-05	8	147	3	3.90.290.10
Domain	TB_dom	FBN1 LTBP4 FBN3	3.88e-05	9	147	3	IPR017878
Domain	TB	FBN1 LTBP4 FBN3	3.88e-05	9	147	3	PS51364
Domain	cEGF	FBN1 SCUBE2 NID1 FBN3	4.81e-05	26	147	4	PF12662
Domain	cEGF	FBN1 SCUBE2 NID1 FBN3	4.81e-05	26	147	4	IPR026823
Domain	RNA_pol_Rpb2_4	POLR2B POLR3B	6.15e-05	2	147	2	PF04566
Domain	RNA_pol_Rpb2_4	POLR2B POLR3B	6.15e-05	2	147	2	IPR007646
Domain	GFP-like	STAB2 STAB1 NID1	7.53e-05	11	147	3	IPR023413
Domain	-	STAB2 STAB1 NID1	7.53e-05	11	147	3	2.40.155.10
Domain	EGF_LAM_2	STAB2 LAMA1 LAMA2 STAB1	8.61e-05	30	147	4	PS50027
Domain	EGF_LAM_1	STAB2 LAMA1 LAMA2 STAB1	8.61e-05	30	147	4	PS01248
Domain	Laminin_G	FAT3 LAMA1 LAMA2 COL18A1 THBS1	9.24e-05	58	147	5	IPR001791
Domain	C8	MUC19 FCGBP MUC5AC	9.98e-05	12	147	3	PF08742
Domain	TIL	MUC19 FCGBP MUC5AC	9.98e-05	12	147	3	PF01826
Domain	EGF_extracell	STAB2 ADAM23 ADAM22 STAB1 NOTCH1	1.09e-04	60	147	5	IPR013111
Domain	EGF_2	STAB2 ADAM23 ADAM22 STAB1 NOTCH1	1.09e-04	60	147	5	PF07974
Domain	Kringle-like	KREMEN1 FN1 MST1 MRC2	1.12e-04	32	147	4	IPR013806
Domain	Unchr_dom_Cys-rich	MUC19 FCGBP MUC5AC	1.29e-04	13	147	3	IPR014853
Domain	C8	MUC19 FCGBP MUC5AC	1.29e-04	13	147	3	SM00832
Domain	EGF_Lam	STAB2 LAMA1 LAMA2 STAB1	1.60e-04	35	147	4	SM00180
Domain	TIL_dom	MUC19 FCGBP MUC5AC	1.63e-04	14	147	3	IPR002919
Domain	-	POLR2B POLR3B	1.84e-04	3	147	2	2.40.270.10
Domain	RNA_pol_RPB2_OB-fold	POLR2B POLR3B	1.84e-04	3	147	2	IPR014724
Domain	RNA_pol_bsu_CS	POLR2B POLR3B	1.84e-04	3	147	2	IPR007121
Domain	DNA-dir_RNA_pol_su2_6	POLR2B POLR3B	1.84e-04	3	147	2	IPR007120
Domain	RNA_pol_Rpb2_7	POLR2B POLR3B	1.84e-04	3	147	2	PF04560
Domain	RNA_pol_Rpb2_2	POLR2B POLR3B	1.84e-04	3	147	2	PF04561
Domain	RNA_pol_Rpb2_5	POLR2B POLR3B	1.84e-04	3	147	2	PF04567
Domain	RNA_pol_Rpb2_1	POLR2B POLR3B	1.84e-04	3	147	2	PF04563
Domain	RNA_pol_Rpb2_3	POLR2B POLR3B	1.84e-04	3	147	2	PF04565
Domain	RNA_pol_Rpb2_5	POLR2B POLR3B	1.84e-04	3	147	2	IPR007647
Domain	RNA_pol_Rpb2_3	POLR2B POLR3B	1.84e-04	3	147	2	IPR007645
Domain	RNA_pol_bsu_protrusion	POLR2B POLR3B	1.84e-04	3	147	2	IPR007644
Domain	RNA_pol_Rpb2_2	POLR2B POLR3B	1.84e-04	3	147	2	IPR007642
Domain	RNA_pol_Rpb2_7	POLR2B POLR3B	1.84e-04	3	147	2	IPR007641
Domain	-	POLR2B POLR3B	1.84e-04	3	147	2	2.40.50.150
Domain	RNA_POL_BETA	POLR2B POLR3B	1.84e-04	3	147	2	PS01166
Domain	-	POLR2B POLR3B	1.84e-04	3	147	2	3.90.1110.10
Domain	DNA-dir_RNA_pol_su2	POLR2B POLR3B	1.84e-04	3	147	2	IPR015712
Domain	RNA_pol_Rpb2_6	POLR2B POLR3B	1.84e-04	3	147	2	PF00562
Domain	FBN	FBN1 FBN3	1.84e-04	3	147	2	IPR011398
Domain	VWFC_2	CRIM1 MUC19 THBS1 MUC5AC	2.21e-04	38	147	4	PS50184
Domain	Laminin_EGF	STAB2 LAMA1 LAMA2 STAB1	2.21e-04	38	147	4	IPR002049
Domain	VWF_type-D	MUC19 FCGBP MUC5AC	2.48e-04	16	147	3	IPR001846
Domain	VWFD	MUC19 FCGBP MUC5AC	2.48e-04	16	147	3	PS51233
Domain	VWD	MUC19 FCGBP MUC5AC	2.48e-04	16	147	3	SM00216
Domain	VWD	MUC19 FCGBP MUC5AC	2.48e-04	16	147	3	PF00094
Domain	FAS1	STAB2 STAB1	3.65e-04	4	147	2	SM00554
Domain	FAS1_domain	STAB2 STAB1	3.65e-04	4	147	2	IPR000782
Domain	BNR_2	NEU4 NEU2	3.65e-04	4	147	2	PF13088
Domain	Sialidase_fam	NEU4 NEU2	3.65e-04	4	147	2	IPR026856
Domain	-	STAB2 STAB1	3.65e-04	4	147	2	2.30.180.10
Domain	FAS1	STAB2 STAB1	3.65e-04	4	147	2	PS50213
Domain	Fasciclin	STAB2 STAB1	3.65e-04	4	147	2	PF02469
Domain	LamG	FAT3 LAMA1 LAMA2 COL18A1	3.92e-04	44	147	4	SM00282
Domain	Laminin_domII	LAMA1 LAMA2	6.06e-04	5	147	2	IPR010307
Domain	Laminin_aI	LAMA1 LAMA2	6.06e-04	5	147	2	IPR009254
Domain	Laminin_I	LAMA1 LAMA2	6.06e-04	5	147	2	PF06008
Domain	Laminin_II	LAMA1 LAMA2	6.06e-04	5	147	2	PF06009
Domain	-	NEU4 NEU2	6.06e-04	5	147	2	2.120.10.10
Domain	WxxW_domain	CILP2 MUC5AC	9.04e-04	6	147	2	IPR025155
Domain	Mucin2_WxxW	CILP2 MUC5AC	9.04e-04	6	147	2	PF13330
Domain	Pan_app	MST1 KLKB1	1.26e-03	7	147	2	IPR003609
Domain	Hirudin/antistatin	CRIM1 MUC5AC	1.26e-03	7	147	2	IPR011061
Domain	PAN	MST1 KLKB1	1.26e-03	7	147	2	PS50948
Domain	PAN_1	MST1 KLKB1	1.26e-03	7	147	2	PF00024
Domain	VWC	CRIM1 THBS1 MUC5AC	1.35e-03	28	147	3	PF00093
Domain	Carb-bd-like_fold	CILP2 GPCPD1	1.67e-03	8	147	2	IPR013784
Domain	LAMININ_IVA	LAMA1 LAMA2	1.67e-03	8	147	2	PS51115
Domain	Laminin_B	LAMA1 LAMA2	1.67e-03	8	147	2	PF00052
Domain	LamB	LAMA1 LAMA2	1.67e-03	8	147	2	SM00281
Domain	Laminin_IV	LAMA1 LAMA2	1.67e-03	8	147	2	IPR000034
Domain	Peptidase_S1A	PAMR1 KLK12 MST1 ELANE KLKB1	2.00e-03	113	147	5	IPR001314
Domain	Sialidases	NEU4 NEU2	2.14e-03	9	147	2	IPR011040
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	COL8A2 FN1 LAMA1 LAMA2 COL18A1 THBS1 FBN1 TLL1 ELANE NID1 LTBP4 KLKB1 FBN3	9.92e-07	300	115	13	M610
Pathway	PID_INTEGRIN1_PATHWAY	FN1 LAMA1 LAMA2 COL18A1 THBS1 FBN1 NID1	1.05e-06	66	115	7	M18
Pathway	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	COL8A2 FN1 COL18A1 FBN1 TLL1 ELANE NID1 KLKB1 FBN3	2.09e-06	140	115	9	M587
Pathway	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	COL8A2 FN1 COL18A1 FBN1 ELANE NID1 KLKB1	4.01e-05	114	115	7	MM14571
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	COL8A2 FN1 COL18A1 THBS1 FBN1 TLL1 ELANE NID1 LTBP4 KLKB1	4.89e-05	258	115	10	MM14572
Pathway	REACTOME_LAMININ_INTERACTIONS	LAMA1 LAMA2 COL18A1 NID1	9.78e-05	30	115	4	M27216
Pathway	REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES	FN1 FBN1 LTBP4 FBN3	2.25e-04	37	115	4	M27134
Pathway	KEGG_OTHER_GLYCAN_DEGRADATION	NEU4 MAN2B1 NEU2	2.74e-04	16	115	3	M17844
Pathway	WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES	ABCA1 LCAT LPL	3.31e-04	17	115	3	M39747
Pathway	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	COL8A2 FN1 COL18A1 THBS1 FBN1	3.86e-04	76	115	5	MM14867
Pathway	PID_INTEGRIN3_PATHWAY	FN1 THBS1 FBN1 PVR	4.06e-04	43	115	4	M53
Pathway	REACTOME_ELASTIC_FIBRE_FORMATION	FN1 FBN1 LTBP4 FBN3	4.44e-04	44	115	4	M26969
Pathway	WP_STATIN_PATHWAY	ABCA1 LCAT LPL	4.66e-04	19	115	3	MM15868
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	FN1 ITLN1 LAMA1 LAMA2 COL18A1 THBS1 FBN1 ELANE NID1 LTBP4 HCFC1	1.75e-10	167	149	11	22159717
Pubmed	Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.	COL8A2 FN1 LAMA2 MST1 COL18A1 FBN1 ELANE NID1 LTBP4	2.25e-08	153	149	9	25037231
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	FN1 LAMA1 LAMA2 COL18A1 THBS1 FBN1 NID1 LTBP4 HCFC1	7.17e-08	175	149	9	28071719
Pubmed	Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.	FN1 LAMA1 COL18A1 THBS1 FBN1 NID1	7.60e-08	50	149	6	23658023
Pubmed	Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud.	FN1 LAMA1 LAMA2 NID1	2.24e-07	13	149	4	9833687
Pubmed	Proteomics characterization of extracellular space components in the human aorta.	COL8A2 FN1 COL18A1 THBS1 FBN1 NID1 LTBP4	2.82e-07	101	149	7	20551380
Pubmed	Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly.	FN1 FBN1 FBN3	3.07e-07	4	149	3	25034023
Pubmed	Munc13‑4 mediates human neutrophil elastase‑induced airway mucin5AC hypersecretion by interacting with syntaxin2.	UNC13D ELANE MUC5AC	3.07e-07	4	149	3	29767240
Pubmed	The first draft of the endostatin interaction network.	FN1 LAMA1 COL18A1 THBS1	3.13e-07	14	149	4	19542224
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	FN1 LAMA1 LAMA2 COL18A1 THBS1 NID1	3.41e-07	64	149	6	22261194
Pubmed	Patterns of laminins and integrins in the embryonic ventricular zone of the CNS.	FN1 LAMA1 LAMA2 NID1	5.66e-07	16	149	4	17948866
Pubmed	Perinatal lethality and endothelial cell abnormalities in several vessel compartments of fibulin-1-deficient mice.	FN1 LAMA2 COL18A1 NID1	5.66e-07	16	149	4	11564885
Pubmed	The human plasma proteome: a nonredundant list developed by combination of four separate sources.	FN1 LCAT THBS1 COCH IGFBP1 AGL KLKB1 MMUT	6.11e-07	165	149	8	14718574
Pubmed	Complete sequence, recombinant analysis and binding to laminins and sulphated ligands of the N-terminal domains of laminin alpha3B and alpha5 chains.	LAMA1 LAMA2 NID1	7.66e-07	5	149	3	11829758
Pubmed	Laminin alpha 2 chain (M chain) is found within the pathway of avian and murine retinal projections.	LAMA1 LAMA2 NID1	7.66e-07	5	149	3	8613743
Pubmed	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	FN1 PAMR1 LAMA1 LAMA2 COL18A1 THBS1 FBN1 NID1 LTBP4	1.35e-06	248	149	9	24006456
Pubmed	Cross-linking of laminin-nidogen complexes by tissue transglutaminase. A novel mechanism for basement membrane stabilization.	LAMA1 LAMA2 NID1	1.53e-06	6	149	3	1678389
Pubmed	Impaired primary mouse myotube formation on crosslinked type I collagen films is enhanced by laminin and entactin.	LAMA1 LAMA2 NID1	1.53e-06	6	149	3	26555376
Pubmed	Effect of basement membrane entactin on epidermal cell attachment and growth.	LAMA1 LAMA2 NID1	1.53e-06	6	149	3	3794389
Pubmed	Laminin-nidogen complex. Extraction with chelating agents and structural characterization.	LAMA1 LAMA2 NID1	1.53e-06	6	149	3	3109910
Pubmed	Structural elucidation of full-length nidogen and the laminin-nidogen complex in solution.	LAMA1 LAMA2 NID1	1.53e-06	6	149	3	23948589
Pubmed	Entactin: structure and function.	LAMA1 LAMA2 NID1	1.53e-06	6	149	3	2119632
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	FLT4 FN1 LAMA2 LCAT MST1 THBS1 FCGBP PVR KLKB1	1.81e-06	257	149	9	16335952
Pubmed	Ror2 knockout mouse as a model for the developmental pathology of autosomal recessive Robinow syndrome.	MYF5 PTCH1 PTH1R NOTCH1	1.83e-06	21	149	4	14745966
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	COL8A2 FN1 LAMA2 COL18A1 FBN1 NID1 LTBP4	2.01e-06	135	149	7	28675934
Pubmed	Notch signaling functions in lymphatic valve formation.	FLT4 FN1 NOTCH1	2.66e-06	7	149	3	24917500
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	FN1 LAMA2 COL18A1 THBS1 FBN1 NID1 LTBP4	3.39e-06	146	149	7	27068509
Pubmed	Discovery and refinement of loci associated with lipid levels.	ABCA1 FN1 LCAT CUBN STAB1 CILP2 LPL OSBPL7	3.85e-06	211	149	8	24097068
Pubmed	Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation.	FN1 LAMA2 COL18A1 FBN1 NID1 LTBP4	4.01e-06	97	149	6	27559042
Pubmed	Common variants of multiple genes that control reverse cholesterol transport together explain only a minor part of the variation of HDL cholesterol levels.	ABCA1 LCAT LPL	4.25e-06	8	149	3	16542392
Pubmed	Mouse AMACO, a kidney and skin basement membrane associated molecule that mediates RGD-dependent cell attachment.	FN1 LAMA1 COL18A1	4.25e-06	8	149	3	19651211
Pubmed	Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins.	FN1 LAMA1 NID1	6.35e-06	9	149	3	9827803
Pubmed	Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice.	FN1 LAMA1 LAMA2	6.35e-06	9	149	3	9882526
Pubmed	Basement membrane assembly of the integrin α8β1 ligand nephronectin requires Fraser syndrome-associated proteins.	FN1 LAMA1 LAMA2 COL18A1	7.07e-06	29	149	4	22613833
Pubmed	Association of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors.	ABCA1 LCAT LPL	9.05e-06	10	149	3	12966036
Pubmed	Genetic analysis of the role of Alx4 in the coordination of lower body and external genitalia formation.	FN1 PTCH1 PITX1	9.05e-06	10	149	3	23942202
Pubmed	Primary cellular meningeal defects cause neocortical dysplasia and dyslamination.	LAMA1 LAMA2 NID1	9.05e-06	10	149	3	20976766
Pubmed	Concordant association of lipid gene variation with a combined HDL/LDL-cholesterol phenotype in two European populations.	ABCA1 LCAT LPL	9.05e-06	10	149	3	16770077
Pubmed	Extracellular Fibrinogen-binding Protein (Efb) from Staphylococcus aureus Inhibits the Formation of Platelet-Leukocyte Complexes.	FN1 UNC13D THBS1	9.05e-06	10	149	3	26627825
Pubmed	Distribution of fibronectin, type I collagen, type IV collagen, and laminin in the cardiac jelly of the mouse embryonic heart with retinoic acid-induced complete transposition of the great arteries.	FN1 LAMA1 FBN1	9.05e-06	10	149	3	9415455
Pubmed	TBX1 is required for normal stria vascularis and semicircular canal development.	STAB1 THBS1 FBN1 NID1	9.30e-06	31	149	4	31550482
Pubmed	Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients.	ABCA1 LCAT CILP2 LPL UCP3	9.77e-06	66	149	5	20679960
Pubmed	Laminin alpha 5 is required for lobar septation and visceral pleural basement membrane formation in the developing mouse lung.	LAMA1 LAMA2 NID1	1.24e-05	11	149	3	12051813
Pubmed	Integrin repertoire on myogenic cells changes during the course of primary myogenesis in the mouse.	MYF5 FN1 LAMA2	1.24e-05	11	149	3	15739233
Pubmed	Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.	MMP27 LAMA2 THBS1 FBN1 MUC5AC	1.40e-05	71	149	5	33541421
Pubmed	Genetic susceptibility to distinct bladder cancer subphenotypes.	ABCA1 CASP9 LCAT COL18A1 LIG4 IGFBP1 SCUBE2 LPL UCP3 NOS2	1.49e-05	421	149	10	19692168
Pubmed	Newly identified loci that influence lipid concentrations and risk of coronary artery disease.	ABCA1 LCAT CILP2 LPL	1.53e-05	35	149	4	18193043
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	CRIM1 IRF2BP1 MAP1A TRIP6 CEP192 FBN1 NOTCH1	1.54e-05	184	149	7	32908313
Pubmed	Disruption of murine Adamtsl4 results in zonular fiber detachment from the lens and in retinal pigment epithelium dedifferentiation.	FN1 COL18A1 FBN1	1.65e-05	12	149	3	26405179
Pubmed	Molecular dissection of laminin alpha 5 in vivo reveals separable domain-specific roles in embryonic development and kidney function.	LAMA1 LAMA2 NID1	1.65e-05	12	149	3	16750824
Pubmed	Matrilin-2 interacts with itself and with other extracellular matrix proteins.	FN1 LAMA1 NID1	1.65e-05	12	149	3	12180907
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	MAN2B1 CRIM1 LAMA1 PIGG ADAM22 COL18A1 THBS1 FBN1 COCH NETO2 MRC2 TLL1 LPL PVR NID1 EDEM1 NOTCH1	1.66e-05	1201	149	17	35696571
Pubmed	Loss of Pancreas upon Activated Wnt Signaling Is Concomitant with Emergence of Gastrointestinal Identity.	RFX6 PTCH1 PITX1 MUC5AC	1.71e-05	36	149	4	27736991
Pubmed	Fibrillin assembly requires fibronectin.	FN1 FBN1	1.82e-05	2	149	2	19037100
Pubmed	Comparison of Fetal Fibronectin and Phosphorylated Insulin-Like Growth Factor Binding Protein-1 Testing to Predict Preterm Delivery in Symptomatic Women: A 10-Year Retrospective Study.	FN1 IGFBP1	1.82e-05	2	149	2	32345553
Pubmed	Stabilin-1 and stabilin-2 are both directed into the early endocytic pathway in hepatic sinusoidal endothelium via interactions with clathrin/AP-2, independent of ligand binding.	STAB2 STAB1	1.82e-05	2	149	2	15572036
Pubmed	High density lipoproteins mediate in vivo protection against staphylococcal phenol-soluble modulins.	ABCA1 LCAT	1.82e-05	2	149	2	34321507
Pubmed	Adrenal Function in females with low plasma HDL-C due to mutations in ABCA1 and LCAT.	ABCA1 LCAT	1.82e-05	2	149	2	24842300
Pubmed	FEEL-1, a novel scavenger receptor with in vitro bacteria-binding and angiogenesis-modulating activities.	STAB2 STAB1	1.82e-05	2	149	2	12077138
Pubmed	Allele-specific enhancers mediate associations between LCAT and ABCA1 polymorphisms and HDL metabolism.	ABCA1 LCAT	1.82e-05	2	149	2	31039173
Pubmed	Inducible nitric oxide synthase up-regulates Notch-1 in mouse cholangiocytes: implications for carcinogenesis.	NOS2 NOTCH1	1.82e-05	2	149	2	15887117
Pubmed	Transgenic overexpression of laminin alpha1 chain in laminin alpha2 chain-deficient mice rescues the disease throughout the lifespan.	LAMA1 LAMA2	1.82e-05	2	149	2	20544910
Pubmed	Further delineation of familial polycystic ovary syndrome (PCOS) via whole-exome sequencing: PCOS-related rare FBN3 and FN1 gene variants are identified.	FN1 FBN3	1.82e-05	2	149	2	35141985
Pubmed	Conserved neuron promoting activity in Drosophila and vertebrate laminin alpha1.	LAMA1 LAMA2	1.82e-05	2	149	2	8663504
Pubmed	Laminin α1 reduces muscular dystrophy in dy2J mice.	LAMA1 LAMA2	1.82e-05	2	149	2	29544677
Pubmed	Identifying Stabilin-1 and Stabilin-2 Double Knockouts in Reproduction and Placentation: A Descriptive Study.	STAB2 STAB1	1.82e-05	2	149	2	33008099
Pubmed	Selective integrin subunit reduction disrupts fibronectin extracellular matrix deposition and fibrillin 1 gene expression.	FN1 FBN1	1.82e-05	2	149	2	22782528
Pubmed	Transient expression of laminin alpha1 chain in regenerating murine liver: restricted localization of laminin chains and nidogen-1.	LAMA1 NID1	1.82e-05	2	149	2	15777791
Pubmed	Deficiency of liver sinusoidal scavenger receptors stabilin-1 and -2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factors.	STAB2 STAB1	1.82e-05	2	149	2	21293057
Pubmed	Requirement of HDAC6 for activation of Notch1 by TGF-β1.	HDAC6 NOTCH1	1.82e-05	2	149	2	27499032
Pubmed	Complex contributions of fibronectin to initiation and maturation of microfibrils.	FN1 FBN1	1.82e-05	2	149	2	24070235
Pubmed	Characterization of free alpha- and beta-chains of recombinant macrophage-stimulating protein.	MST1 KLKB1	1.82e-05	2	149	2	10068459
Pubmed	HDAC6 Mediates Macrophage iNOS Expression and Excessive Nitric Oxide Production in the Blood During Endotoxemia.	HDAC6 NOS2	1.82e-05	2	149	2	32973784
Pubmed	FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products.	STAB2 STAB1	1.82e-05	2	149	2	12473645
Pubmed	Laminin 2 attachment selects myofibroblasts from fetal mouse lung.	LAMA1 LAMA2	1.82e-05	2	149	2	9728058
Pubmed	Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CVB3-induced viral myocarditis.	FN1 STAB1	1.82e-05	2	149	2	34968453
Pubmed	Mechanism for phosphatidylserine-dependent erythrophagocytosis in mouse liver.	STAB2 STAB1	1.82e-05	2	149	2	21427291
Pubmed	Phenotypical and biochemical characterization of murine psoriasiform and fibrotic skin disease models in Stabilin-deficient mice.	STAB2 STAB1	1.82e-05	2	149	2	38946049
Pubmed	Cholesterol homeostasis in ABCA1/LCAT double-deficient mouse.	ABCA1 LCAT	1.82e-05	2	149	2	19729076
Pubmed	Collagen XVIII short isoform is critical for retinal vascularization, and overexpression of the Tsp-1 domain affects eye growth and cataract formation.	COL18A1 THBS1	1.82e-05	2	149	2	24135756
Pubmed	αv-Class integrin binding to fibronectin is solely mediated by RGD and unaffected by an RGE mutation.	FN1 NID1	1.82e-05	2	149	2	33141174
Pubmed	Scavenging Endothelium of Pancreatic Islets: Differential Expression of Stabilin-1 and Stabilin-2 in Mice and Humans.	STAB2 STAB1	1.82e-05	2	149	2	27977633
Pubmed	The endocytic receptor uPARAP is a regulator of extracellular thrombospondin-1.	THBS1 MRC2	1.82e-05	2	149	2	35878760
Pubmed	LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations.	LPL NOTCH1	1.82e-05	2	149	2	26558352
Pubmed	Exploring the transcriptomic network of multi-ligand scavenger receptor Stabilin-1- and Stabilin-2-deficient liver sinusoidal endothelial cells.	STAB2 STAB1	1.82e-05	2	149	2	33130055
Pubmed	Three novel mutations of the fibrillin-1 gene and ten single nucleotide polymorphisms of the fibrillin-3 gene in Marfan syndrome patients.	FBN1 FBN3	1.82e-05	2	149	2	15221638
Pubmed	Mycobacterium tuberculosis malate synthase is a laminin-binding adhesin.	FN1 LAMA1	1.82e-05	2	149	2	16677310
Pubmed	Incorporation of thrombospondin into fibrin clots.	FN1 THBS1	1.82e-05	2	149	2	3997886
Pubmed	Circular RNA THBS1 promotes proliferation and apoptosis of non-small cell lung cancer cells by sponging miR-129-5p and regulating SOX4 expression.	SOX4 THBS1	1.82e-05	2	149	2	33099906
Pubmed	Fibrillin-1 microfibril deposition is dependent on fibronectin assembly.	FN1 FBN1	1.82e-05	2	149	2	18653538
Pubmed	Characterization of the interaction between endostatin short peptide and VEGF receptor 3.	FLT4 COL18A1	1.82e-05	2	149	2	22512651
Pubmed	Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues.	STAB2 STAB1	1.82e-05	2	149	2	11829752
Pubmed	Distinct roles for laminin globular domains in laminin alpha1 chain mediated rescue of murine laminin alpha2 chain deficiency.	LAMA1 LAMA2	1.82e-05	2	149	2	20657839
Pubmed	Modified Ca(v)1.4 expression in the Cacna1f(nob2) mouse due to alternative splicing of an ETn inserted in exon 2.	CACNA1F FLNA	1.82e-05	2	149	2	18596967
Pubmed	Association of Differentially Altered Liver Fibrosis with Deposition of TGFBi in Stabilin-Deficient Mice.	STAB2 STAB1	1.82e-05	2	149	2	37446152
Pubmed	Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression.	FN1 LAMA1	1.82e-05	2	149	2	25885552
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	CACNA1F FN1 LAMA1 MYOM3 MUC19 GRIK5 CSMD2 CHML MST1 YOD1 AGL RECQL4 FBN3	1.84e-05	736	149	13	29676528
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	SOX4 ZFP42 KREMEN1 ADAM23 ZNF423 FAT3 LAMA2 CHML COL18A1 ARSL RECQL4 NID1 EDEM1 KLKB1 FBN3 NOTCH1 PRODH	1.93e-05	1215	149	17	15146197
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SOX4 FLNA CRYBG2 MAN2B1 MYOM3 CEP192 PIGG PTCH1 BABAM2 BAHD1 CASKIN1 PITX1 KBTBD11 LTBP4 HCFC1 NOTCH1	2.28e-05	1105	149	16	35748872
Pubmed	Transcriptome-based systematic identification of extracellular matrix proteins.	LAMA1 LAMA2 COL18A1 THBS1 NID1	2.36e-05	79	149	5	18757743
Interaction	FBXO2 interactions	MAN2B1 FN1 ADAM23 LAMA1 COL18A1 CILP2 FBN1 COCH MRC2 PVR NID1 LTBP4 NOTCH1	1.19e-05	411	149	13	int:FBXO2
Interaction	HOXA1 interactions	RALGDS FN1 TRIP6 KRT82 BAHD1 PTH1R FBN1 PVR PITX1 INCA1 LTBP4 NOTCH1	1.39e-05	356	149	12	int:HOXA1
Coexpression	NABA_MATRISOME	COL8A2 FN1 CRIM1 PAMR1 ADAM23 ITLN1 LAMA1 MMP27 MUC19 LAMA2 RSPO4 ADAM22 ZP1 MST1 COL18A1 THBS1 CILP2 FBN1 COCH IGFBP1 SCUBE2 TLL1 ELANE NID1 LTBP4 MUC5AC HCFC1 FBN3	3.85e-12	1026	148	28	M5889
Coexpression	NABA_CORE_MATRISOME	COL8A2 FN1 CRIM1 LAMA1 LAMA2 RSPO4 ZP1 COL18A1 THBS1 CILP2 FBN1 COCH IGFBP1 NID1 LTBP4 FBN3	4.41e-12	275	148	16	M5884
Coexpression	NABA_ECM_GLYCOPROTEINS	FN1 CRIM1 LAMA1 LAMA2 RSPO4 ZP1 THBS1 CILP2 FBN1 COCH IGFBP1 NID1 LTBP4 FBN3	6.56e-12	196	148	14	M3008
Coexpression	NABA_MATRISOME	COL8A2 FN1 CRIM1 PAMR1 ADAM23 ITLN1 LAMA1 MMP27 MUC19 LAMA2 RSPO4 ADAM22 ZP1 MST1 COL18A1 THBS1 CILP2 FBN1 COCH IGFBP1 SCUBE2 TLL1 ELANE NID1 LTBP4 MUC5AC HCFC1	1.51e-11	1008	148	27	MM17056
Coexpression	NABA_CORE_MATRISOME	COL8A2 FN1 CRIM1 LAMA1 LAMA2 RSPO4 ZP1 COL18A1 THBS1 CILP2 FBN1 COCH IGFBP1 NID1 LTBP4	4.09e-11	270	148	15	MM17057
Coexpression	NABA_ECM_GLYCOPROTEINS	FN1 CRIM1 LAMA1 LAMA2 RSPO4 ZP1 THBS1 CILP2 FBN1 COCH IGFBP1 NID1 LTBP4	7.01e-11	191	148	13	MM17059
Coexpression	CAIRO_LIVER_DEVELOPMENT_DN	STAB2 FN1 GRIK5 LCAT MST1 COL18A1 IGFBP1 ELANE NID1 KLKB1	6.45e-07	225	148	10	M6175
Coexpression	CAIRO_LIVER_DEVELOPMENT_DN	STAB2 FN1 GRIK5 LCAT MST1 COL18A1 IGFBP1 ELANE NID1 KLKB1	1.12e-06	239	148	10	MM1274
Coexpression	PETRETTO_CARDIAC_HYPERTROPHY	FN1 CRIM1 FBN1 LPL NID1	1.31e-06	34	148	5	M14043
Coexpression	HALLMARK_COAGULATION	FN1 CASP9 MST1 THBS1 FBN1 WDR1 KLKB1	1.39e-05	138	148	7	M5946
Coexpression	GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN	FLNA RALGDS STAB2 GIT1 CD300A ADAM22 ASPA GPCPD1	1.89e-05	200	148	8	M6626
Coexpression	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	FLNA COL8A2 FN1 LAMA1 LAMA2 THBS1 FBN1 PVR	1.89e-05	200	148	8	M5930
Coexpression	TABULA_MURIS_SENIS_MAMMARY_GLAND_MACROPHAGE_AGEING	FLNA MAN2B1 FN1 THBS1 LPL UQCRC1	1.90e-05	97	148	6	MM3789
Coexpression	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	STAB2 HDAC6 TRIP6 LCAT PTH1R STAB1 PVR LTBP4 KLKB1	2.70e-05	274	148	9	M13014
Coexpression	NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR	FN1 LAMA1 COL18A1 NID1	4.46e-05	35	148	4	MM17054
Coexpression	HU_FETAL_RETINA_FIBROBLAST	FLNA FN1 LAMA1 PTCH1 PTH1R FBN1 MRC2 PITX1 NID1 LTBP4	7.03e-05	385	148	10	M39264
Coexpression	CHEN_METABOLIC_SYNDROM_NETWORK	FLNA RALGDS MAN2B1 CD300A MMP27 LAMA2 UNC13D DENND1C STAB1 FBN1 CSF2RB GPATCH3 OSBPL3 LPL NID1 WDR1 KLKB1 PRODH ADSS1	7.61e-05	1242	148	19	M1920
Coexpression	NABA_BASEMENT_MEMBRANES	LAMA1 LAMA2 COL18A1 NID1	7.62e-05	40	148	4	M5887
Coexpression	ROSS_AML_WITH_PML_RARA_FUSION	MAP1A STAB1 MST1 MRC2 PRODH	9.17e-05	80	148	5	M15368
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HRGL2C	ERF LAMA1 PTCH1 RFC3 CSMD2 CSMD3 SCUBE2 MRC2 NOTCH1	1.01e-04	325	148	9	M39053
Coexpression	LIU_PROSTATE_CANCER_DN	FLNA CRIM1 TRIP6 LCAT FBN1 FCGBP COCH SCUBE2 MRC2 NID1 WDR1	1.18e-04	493	148	11	M19391
Coexpression	GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP	FLNA ABCA1 ERF TRIP4 LPL EDEM1 KLKB1	1.25e-04	195	148	7	M8421
Coexpression	GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP	FLNA ZNF423 DDX11 ARSL MRC2 OSBPL3 TLL1	1.33e-04	197	148	7	M8414
Coexpression	GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS	FLNA LCAT PTCH1 CSMD3 PTH1R COL18A1 FBN1 SCUBE2 MRC2 PITX1 NID1	1.45e-04	505	148	11	M39167
Coexpression	GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP	HDAC6 PTCH1 ELP3 COL18A1 THBS1 LPL ADSS1	1.46e-04	200	148	7	M9691
Coexpression	FEKIR_HEPARG_SIDE_POP_VS_HEPARG_UP	FLNA CRYBG2 UNC13D LCAT IGFBP1	1.60e-04	90	148	5	M48360
Coexpression	CHEN_METABOLIC_SYNDROM_NETWORK	FLNA RALGDS MAN2B1 CD300A MMP27 LAMA2 UNC13D DENND1C STAB1 FBN1 CSF2RB GPATCH3 OSBPL3 LPL NID1 WDR1 KLKB1 PRODH ADSS1	1.61e-04	1316	148	19	MM1052
Coexpression	ZHANG_UTERUS_C14_ENDOTHELIAL_MMRN1_HIGH_CELL	FLT4 DUSP2 STAB1 LTBP4	1.70e-04	49	148	4	MM16620
Coexpression	KRAS.600_UP.V1_DN	CD300A KLK12 DENND1C YOD1 FCGBP CIITA MUC5AC PRODH	1.94e-04	279	148	8	M2880
Coexpression	HU_ANGIOGENESIS_UP	LCAT THBS1 PRODH	2.18e-04	21	148	3	M6967
CoexpressionAtlas	Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4	FLT4 STAB2 FN1 STAB1 THBS1 FBN1 NID1 LTBP4	2.05e-07	91	145	8	GSM777059_100
CoexpressionAtlas	Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4	FLT4 STAB2 FN1 STAB1 THBS1 NID1 LTBP4	4.30e-06	96	145	7	GSM777063_100
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	FLNA FN1 MYO1A MAP1A ADAM23 ZNF423 FAT3 LAMA1 LAMA2 CEP192 PTCH1 PTH1R THBS1 FBN1 NETO2 MRC2 NID1 LTBP4	6.10e-06	777	145	18	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000	FLNA FN1 CRIM1 PAMR1 ADAM23 FAT3 LAMA1 CUBN CHML ADAM22 PTH1R THBS1 FBN1 AGL ASPA KBTBD11 NID1 WDR1 ADSS1	1.33e-05	905	145	19	gudmap_kidney_P0_JuxtaGlom_Ren1_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200	ADAM23 FAT3 LAMA2 PTCH1 FBN1 LTBP4	2.09e-05	82	145	6	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500	FN1 ADAM23 FAT3 LAMA1 LAMA2 PTCH1 FBN1 LTBP4	3.66e-05	182	145	8	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500
CoexpressionAtlas	Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4	ABCA1 FLT4 STAB2 FN1 CRIM1 STAB1 THBS1 FBN1 COCH TLL1 NID1 LTBP4	4.97e-05	439	145	12	GSM777059_500
CoexpressionAtlas	Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3	LAMA2 THBS1 FBN1 LPL NID1 LTBP4	5.42e-05	97	145	6	GSM777043_100
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000	FLNA MYO1A FAT3 LAMA1 LAMA2 PTCH1 FBN1 MRC2 ZNF319 LTBP4	5.52e-05	310	145	10	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000
CoexpressionAtlas	Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4	ABCA1 FLT4 STAB2 FN1 CRIM1 STAB1 THBS1 FBN1 COCH TLL1 NID1 LTBP4	6.30e-05	450	145	12	GSM777063_500
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000	FLNA CAND2 ZNF423 FAT3 LAMA1 LAMA2 PTCH1 FBN1 MRC2 LTBP4	1.08e-04	336	145	10	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000
CoexpressionAtlas	Myeloid Cells, DC.103-11b+.Lv, CD45+ CD11c+ MHC-II + CD11b high CD103-, Liver, avg-3	FLT4 STAB2 FN1 ADAM23 CD300A STAB1 THBS1 CSF2RB CIITA LPL NID1	1.24e-04	411	145	11	GSM538239_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	FLNA ABCA1 MYO1A FAT3 LAMA1 LAMA2 PTCH1 COL18A1 FBN1 NETO2 MRC2 LPL NID1 ZNF319 LTBP4	2.51e-04	768	145	15	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000	FLNA ABCA1 CAND2 FN1 ADAM23 ZNF423 FAT3 LAMA1 LAMA2 PTCH1 FBN1 NETO2 MRC2 NID1 LTBP4	2.69e-04	773	145	15	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500	FN1 FAT3 LAMA1 PTCH1 FBN1 LTBP4	2.72e-04	130	145	6	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500
CoexpressionAtlas	Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2	FN1 THBS1 FBN1 LPL NID1	2.93e-04	85	145	5	GSM777067_100
CoexpressionAtlas	alpha beta T cells, NKT.44+NK1.1+.Th, aGC CD1d tet CD3e CD44 NK1.1, Thymus, avg-3	CRYBG2 ABCA1 CRIM1 DUSP2 CHD7 TRIP4 OSBPL3 PVR KBTBD11 IL27RA	3.22e-04	385	145	10	GSM538332_500
CoexpressionAtlas	Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5	FN1 PAMR1 THBS1 FBN1 NID1	3.27e-04	87	145	5	GSM777050_100
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000	ZNF423 FAT3 LAMA2 PTCH1 FBN1 NID1 LTBP4	3.47e-04	191	145	7	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	FLNA FN1 MYO1A MAP1A ZNF423 FAT3 LAMA1 LAMA2 CEP192 PTCH1 THBS1 FBN1 NETO2 NID1 LTBP4	3.53e-04	793	145	15	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABCA1 FN1 LAMA1 PTCH1 THBS1 FBN1 MRC2 LPL NID1 LTBP4	1.46e-09	199	149	10	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	FN1 FAT3 LAMA2 PTH1R FBN1 NALF1 MRC2 ASPA NID1 LTBP4	1.46e-09	199	149	10	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FN1 LAMA1 PTCH1 THBS1 FBN1 SCUBE2 MRC2 LPL NID1 LTBP4	1.54e-09	200	149	10	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	ABCA1 LAMA1 PTCH1 THBS1 FBN1 SCUBE2 MRC2 LPL NID1 LTBP4	1.54e-09	200	149	10	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCA1 FLT4 STAB2 ZNF423 STAB1 COL18A1 TLL1 KBTBD11 LTBP4	1.66e-08	190	149	9	26e2237f65cb43723c5da853831b40df2982d6e4
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCA1 FLT4 STAB2 ZNF423 STAB1 COL18A1 TLL1 KBTBD11 LTBP4	1.66e-08	190	149	9	a1514d2186eb4fe569971ab22dc0c17d353fb94a
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCA1 FLT4 STAB2 ZNF423 STAB1 COL18A1 TLL1 KBTBD11 LTBP4	1.66e-08	190	149	9	0bb954a94317cfc742b9b6221bb80f8baa6d3ff1
ToppCell	facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 FLT4 STAB2 ZNF423 STAB1 COL18A1 TLL1 KBTBD11 LTBP4	1.73e-08	191	149	9	48823a97c38263f2c6e58348214f5b62773a6368
ToppCell	facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 FLT4 STAB2 ZNF423 STAB1 COL18A1 TLL1 KBTBD11 LTBP4	1.73e-08	191	149	9	0eedc66e967b1837ce2c14f8c14b3c1eba868c76
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABCA1 FN1 FAT3 RSPO4 COL18A1 THBS1 NALF1 MRC2 LPL	1.73e-08	191	149	9	08720998aa55131d7377c4c67c4c935865bd7d79
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SOX4 FN1 PAMR1 FBN1 MRC2 PITX1 ASPA NID1 LTBP4	1.81e-08	192	149	9	f053b89bfd6048c227667ff01c38df7c51d8a496
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	FN1 FAT3 LAMA2 PTH1R FBN1 NALF1 MRC2 ASPA NID1	1.90e-08	193	149	9	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FN1 FAT3 LAMA2 CSMD3 FBN1 NALF1 MRC2 LPL ASPA	1.98e-08	194	149	9	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	21-Trachea-Mesenchymal-Mesenchyme_RSPO2+\|Trachea / Age, Tissue, Lineage and Cell class	FN1 ZNF423 FAT3 LAMA2 RSPO4 PTH1R FBN1 LPL ASPA	1.98e-08	194	149	9	8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3
ToppCell	ASK428-Mesenchymal\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	FN1 PAMR1 LAMA2 COL18A1 THBS1 FBN1 ASPA NID1 LTBP4	2.07e-08	195	149	9	2b156163975d9a3d3fda1402acd9831d0fdc9e25
ToppCell	ASK428-Mesenchymal-Fibroblast\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	FN1 PAMR1 LAMA2 COL18A1 THBS1 FBN1 ASPA NID1 LTBP4	2.07e-08	195	149	9	c269c0d894a0f55da6495b59d4b9abb9f68df684
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FN1 FAT3 LAMA2 RSPO4 FBN1 MRC2 ASPA NID1 LTBP4	2.07e-08	195	149	9	4243190ad291d56694e2155954dbaa879c9d3844
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SOX4 FN1 PAMR1 FBN1 MRC2 PITX1 ASPA NID1 LTBP4	2.17e-08	196	149	9	cbfe01ba8071864e19b37028236ae35789f630fe
ToppCell	Tracheal-10x5prime-Stromal-Peri/Epineurial_\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FN1 THEM5 LAMA2 PTCH1 CSMD3 FBN1 MRC2 NID1 LTBP4	2.26e-08	197	149	9	2cb1f557ce1400398975de94638126b4522567f3
ToppCell	Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FN1 THEM5 LAMA2 NMUR1 PTCH1 FBN1 NID1 LTBP4 NXPH3	2.37e-08	198	149	9	7a0c4dbc8c99968d42af00a718f4fedc544599ec
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FN1 FAT3 LAMA2 RSPO4 FBN1 MRC2 ASPA NID1 LTBP4	2.37e-08	198	149	9	f1374f7a50244d59c766ac41f44c08c9117407d2
ToppCell	PCW_10-12-Mesenchymal\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FN1 FAT3 LAMA2 PTH1R FBN1 NALF1 MRC2 LPL LTBP4	2.47e-08	199	149	9	a09292de4c4447b8eee55d401808e43b817321cc
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FN1 FAT3 LAMA2 RSPO4 FBN1 MRC2 ASPA NID1 LTBP4	2.47e-08	199	149	9	66a79732caf2f04c09b4d9832377aa01ca477677
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FN1 MAP1A PAMR1 LAMA2 THBS1 FBN1 PITX1 NID1 LTBP4	2.58e-08	200	149	9	a2bb67a06757f19be3f56f8cb5bb7e2affa5f4ed
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FN1 MAP1A PAMR1 LAMA2 THBS1 FBN1 PITX1 NID1 LTBP4	2.58e-08	200	149	9	10f0c20ba7c71d9e2e177597f85b41cb40f0d878
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	MAP1A PAMR1 LAMA2 PTCH1 ADAM22 PTH1R FBN1 NID1 LTBP4	2.58e-08	200	149	9	a9ff3210127000b3dd9e97136163c98c2b0817d7
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCA1 FN1 LAMA2 PTCH1 COL18A1 FBN1 NID1 LTBP4	1.07e-07	169	149	8	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 MAP1A PAMR1 FAT3 LAMA2 FBN1 NID1 LTBP4	1.80e-07	181	149	8	c62b0a2422377ffadaab63edd538e87a06fa5017
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 MAP1A PAMR1 FAT3 LAMA2 FBN1 NID1 LTBP4	1.80e-07	181	149	8	c6d2a13df3b74fade3b0c71e285b4c14c8e52413
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FN1 LAMA2 COL18A1 FBN1 SCUBE2 MRC2 NID1 LTBP4	1.88e-07	182	149	8	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 STAB2 CRIM1 ADAM23 PIGG STAB1 NID1 LTBP4	1.96e-07	183	149	8	709a486154b3157427deb3b8886b63ac39ea42dd
ToppCell	droplet-Liver-nan-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 STAB2 CRIM1 ADAM23 PIGG STAB1 NID1 LTBP4	1.96e-07	183	149	8	dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 PAMR1 ADAM23 LAMA2 FBN1 MRC2 LPL NID1	2.13e-07	185	149	8	00258f458cbf6d36449db95528a6b5038d731d2d
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 PAMR1 ADAM23 LAMA2 FBN1 MRC2 LPL NID1	2.13e-07	185	149	8	3cd0686a14e734a0f243070ab939adcb4c454478
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 PAMR1 ADAM23 LAMA2 FBN1 MRC2 LPL NID1	2.13e-07	185	149	8	a94694e226856bc5b168464f52d76004145717a5
ToppCell	3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLNA CAND2 FN1 PTCH1 ZP1 PITX1 ELANE NID1	2.61e-07	190	149	8	591310e615700321a010a4b90405cbbbbdb3aade
ToppCell	facs-Liver-Non-hepatocytes-24m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 STAB2 CRIM1 ADAM23 STAB1 NID1 LTBP4 NOTCH1	2.83e-07	192	149	8	d525f7f088a53110912600a7c9f6d33b9270d534
ToppCell	facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 STAB2 CRIM1 ADAM23 STAB1 NID1 LTBP4 NOTCH1	2.83e-07	192	149	8	2bfac6b3956265205ca47d06888851ed68b65999
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL8A2 FN1 LAMA2 CILP2 FBN1 MRC2 NID1 LTBP4	2.94e-07	193	149	8	428b1a3ad87dff7f65de5161d40f102572a9341b
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 PAMR1 LAMA2 FBN1 MRC2 ELANE NID1 LTBP4	3.06e-07	194	149	8	d3db241ea316bbcde6d16618193b474591ad5ce4
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	FN1 PAMR1 LAMA2 NAALADL2 FBN1 MRC2 NID1 LTBP4	3.06e-07	194	149	8	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	metastatic_Brain-Fibroblasts-Pericytes\|metastatic_Brain / Location, Cell class and cell subclass	FN1 MAP1A PAMR1 LAMA2 PTH1R ZP1 COL18A1 NID1	3.06e-07	194	149	8	d1889a3e22d5b88461c81ec3ea0e74bb9bf63e60
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 PAMR1 LAMA2 FBN1 MRC2 ELANE NID1 LTBP4	3.06e-07	194	149	8	02b8102be9414d6964cd71019613edff6d88b893
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 PAMR1 LAMA2 FBN1 MRC2 ELANE NID1 LTBP4	3.06e-07	194	149	8	29f83cdd63314fff41258937d70b881a5503bfcc
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FN1 FAT3 LAMA2 PTCH1 PTH1R FBN1 NALF1 MRC2	3.06e-07	194	149	8	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 STAB2 CRIM1 ADAM23 STAB1 NID1 LTBP4 NOTCH1	3.18e-07	195	149	8	12ba6d95e42d06b1991b011043c0e3370a7b4131
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	FN1 CRIM1 FAT3 LAMA2 PTH1R FBN1 ASPA NID1	3.18e-07	195	149	8	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FN1 FAT3 LAMA2 PTH1R NALF1 MRC2 ASPA LTBP4	3.18e-07	195	149	8	1cdf5f296029ae424d9dba42e86a6d111e4896e6
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	FN1 PAMR1 LAMA2 NAALADL2 FBN1 MRC2 NID1 LTBP4	3.18e-07	195	149	8	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	facs-Bladder-nan-3m-Epithelial-bladder_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 PAMR1 ADAM23 LAMA2 FBN1 MRC2 PITX1 NID1	3.18e-07	195	149	8	223f5f07dc28fa13a09bb589884c58043c7928c7
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FN1 FAT3 LAMA2 RSPO4 FBN1 MRC2 NID1 LTBP4	3.18e-07	195	149	8	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCA1 FN1 LAMA2 PTCH1 COL18A1 FBN1 NID1 LTBP4	3.31e-07	196	149	8	2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FN1 FAT3 LAMA2 RSPO4 FBN1 MRC2 NID1 LTBP4	3.31e-07	196	149	8	42e9828222a9663525d571633e8a454c30bfa7f8
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 LAMA2 COL18A1 THBS1 FBN1 MRC2 NID1 LTBP4	3.44e-07	197	149	8	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FN1 FAT3 LAMA2 RSPO4 MRC2 ASPA NID1 LTBP4	3.44e-07	197	149	8	13896ec65ccda0b928c91d41112dc01b480036b7
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FN1 FAT3 LAMA2 PTH1R NALF1 LPL ASPA LTBP4	3.44e-07	197	149	8	31a1852911bda38543916585fda34255fd62a134
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 LAMA2 COL18A1 THBS1 FBN1 MRC2 NID1 LTBP4	3.44e-07	197	149	8	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	PCW_13-14-Mesenchymal\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FN1 FAT3 LAMA2 PTH1R FBN1 NALF1 MRC2 LTBP4	3.44e-07	197	149	8	73a2085d2682d636726a5432d572ae2a3fbe1c3f
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FN1 FAT3 LAMA2 CSMD3 NAALADL2 NALF1 LPL ASPA	3.44e-07	197	149	8	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FN1 PTCH1 COL18A1 MRC2 PITX1 ELANE NID1 LTBP4	3.58e-07	198	149	8	0f4052a59c6bd89dab637d6ef1214460d6cbcf55
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FN1 FAT3 LAMA2 THBS1 FBN1 NALF1 MRC2 ASPA	3.58e-07	198	149	8	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FN1 FAT3 LAMA2 PTH1R NALF1 LPL ASPA LTBP4	3.58e-07	198	149	8	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FLNA PAMR1 LAMA2 PTCH1 ADAM22 FBN1 NID1 LTBP4	3.72e-07	199	149	8	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FN1 PTCH1 THBS1 FBN1 MRC2 LPL NID1 LTBP4	3.72e-07	199	149	8	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	ABCA1 FN1 LAMA2 COL18A1 THBS1 FBN1 MRC2 NID1	3.72e-07	199	149	8	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	metastatic_Brain-Fibroblasts\|metastatic_Brain / Location, Cell class and cell subclass	FN1 MAP1A PAMR1 LAMA2 PTH1R COL18A1 FBN1 NID1	3.72e-07	199	149	8	63eb2106bb6e2e33d020628583536c8d96662c84
ToppCell	Skin-Fibroblasts\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	FN1 MMP27 LAMA2 THBS1 FBN1 COCH ELANE NID1	3.86e-07	200	149	8	f777eadf571a1a6d246da87346a9cb9d511c2e81
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FN1 MAP1A PAMR1 LAMA2 THBS1 FBN1 NID1 LTBP4	3.86e-07	200	149	8	db6281b5d4032116310db379d9175d790994c99c
ToppCell	5'-Adult-SmallIntestine-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLNA FN1 PAMR1 LAMA2 FBN1 MRC2 NID1 LTBP4	3.86e-07	200	149	8	a637281d91e95734ee4f8510b3780e0272b16fda
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FN1 FAT3 LAMA2 PTH1R THBS1 FBN1 ASPA NID1	3.86e-07	200	149	8	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	wk_20-22-Mesenchymal-Fibroblast-intermediate_fibro\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	FN1 PAMR1 THBS1 FBN1 MRC2 ASPA NID1 LTBP4	3.86e-07	200	149	8	d769723f8fcb37d9b86589e0c41c1d7f16393cfe
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	FLNA MAP1A PAMR1 PTCH1 ADAM22 FBN1 NID1 LTBP4	3.86e-07	200	149	8	02cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCell	TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-4\|TCGA-Bladder / Sample_Type by Project: Shred V9	RALGDS PAMR1 DUSP2 MMP27 NALF1 ASPA ELANE	7.51e-07	150	149	7	bcb99c6fa81052556ab30f9db5875fccf1ae724b
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 STAB2 MYO1A ADAM23 FAT3 STAB1 NID1	9.36e-07	155	149	7	8fdda4e3657ac56188ae88ed3caf145f4d9d1567
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7B FAT3 LAMA1 MUC19 LAMA2 TLL1 MOV10L1	1.16e-06	160	149	7	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7B FAT3 LAMA1 MUC19 LAMA2 TLL1 MOV10L1	1.16e-06	160	149	7	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	PND10-Endothelial-Endothelial_lymphatic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABCA1 FLT4 STAB2 STAB1 COL18A1 CILP2 COCH	1.37e-06	164	149	7	f13b8d9b7f42193f333d9a77571a1dde6bbb48d8
ToppCell	PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABCA1 FLT4 STAB2 STAB1 COL18A1 CILP2 COCH	1.37e-06	164	149	7	4cfc9f92e49f86d3639e018b35b6a60dc62f494a
ToppCell	PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABCA1 FLT4 STAB2 STAB1 COL18A1 CILP2 COCH	1.37e-06	164	149	7	7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6
ToppCell	PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABCA1 FLT4 STAB2 STAB1 COL18A1 CILP2 COCH	1.37e-06	164	149	7	5e5bd81414ea2d64f73cdef19a0a78c17bec8c18
ToppCell	facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-T_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DUSP2 DENND1C NETO2 WDR6 KBTBD11 GPCPD1 ZSCAN2	1.60e-06	168	149	7	182f08106ac65ea501e2fb9139d3b44b7c4662c9
ToppCell	ASK452-Endothelial-Lymphatic\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	ZNF449 FLT4 STAB2 PHOSPHO2 TRIP4 ADAM22 KBTBD11	2.19e-06	176	149	7	b4d280ecc07701d526f50d44c45ea91b3eeb00b1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PAMR1 ZNF423 LAMA2 NALF1 LPL NID1 LTBP4	2.27e-06	177	149	7	9ec7f1e64312d26d434b3312b58386715dbad644
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PAMR1 ZNF423 LAMA2 NALF1 LPL NID1 LTBP4	2.27e-06	177	149	7	016277dfd59b1793fddaaadc2b3f41622d76ce3a
ToppCell	LA-01._Fibroblast_I\|LA / Chamber and Cluster_Paper	PAMR1 LAMA2 FBN1 MRC2 ELANE NID1 LTBP4	2.45e-06	179	149	7	dcb6ec9ae72b13fe388b72dace2815293fafe8ee
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCA1 FN1 PTH1R COL18A1 FBN1 NID1 LTBP4	2.54e-06	180	149	7	f2f6e83127a4a415e65c76a35efa8175fbd5b5d9
ToppCell	droplet-Liver-nan-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 STAB2 CRIM1 CASP9 STAB1 NID1 LTBP4	2.63e-06	181	149	7	fcc94f04dae98b817ec06b282d2e887804d37ae5
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FN1 FAT3 LAMA2 PTH1R FBN1 NALF1 ASPA	2.63e-06	181	149	7	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLT4 STAB2 STAB1 CILP2 COCH KBTBD11 ZSCAN2	2.63e-06	181	149	7	cc77ac0e223e012767222e45c5dcadc246d1aa7c
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLT4 STAB2 STAB1 CILP2 COCH KBTBD11 ZSCAN2	2.63e-06	181	149	7	b0fff0defba9aea6fba36e378b05a59986e2573a
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLT4 STAB2 STAB1 CILP2 COCH KBTBD11 ZSCAN2	2.63e-06	181	149	7	ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa
ToppCell	facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCA1 FLT4 STAB2 ZNF423 STAB1 KBTBD11 LTBP4	2.73e-06	182	149	7	2cc434e46985c66fc36de05344a67aa96d90abc9
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PAMR1 FAT3 LAMA2 FBN1 MRC2 NID1 LTBP4	2.73e-06	182	149	7	b7d532feb73167e05475855061b35a209583f44c
ToppCell	facs-Lung-24m-Endothelial-lymphatic_endothelial\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCA1 FLT4 STAB2 ZNF423 STAB1 KBTBD11 LTBP4	2.73e-06	182	149	7	0cde2775bdaaa2172499925bd59b0ac2d545eb27
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PAMR1 FAT3 LAMA2 FBN1 MRC2 NID1 LTBP4	2.73e-06	182	149	7	af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c
ToppCell	facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCA1 FLT4 STAB2 ZNF423 STAB1 KBTBD11 LTBP4	2.73e-06	182	149	7	3e7457b2a70b45735fb75d6617b7f34cef28758e
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FLT4 STAB2 GIT1 COL18A1 TLL1 KBTBD11 NOTCH1	2.83e-06	183	149	7	bc98df870de65aff6dab295c24cbc199c7f2aa15
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F STAB2 MYO7B FAT3 LAMA1 CSMD3 GUCY2F	2.93e-06	184	149	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F STAB2 MYO7B FAT3 LAMA1 CSMD3 GUCY2F	2.93e-06	184	149	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F STAB2 MYO7B FAT3 LAMA1 CSMD3 GUCY2F	2.93e-06	184	149	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
Computational	Neighborhood of TNFRSF25	ABCA1 GRIK5 BAHD1 PTH1R DDX11 TRIM66 ARSL PVR LTBP4 NOS2	8.01e-05	266	91	10	MORF_TNFRSF25
Drug	mono-(2-ethylhexyl)phthalate	STAB2 ADAM23 NUP210L BEAN1 MYOM3 CASP9 UNC13D CUBN PTCH1 ADAM22 THBS1 FCGBP WDR6 AGL MOV10L1 TAF1 FER1L5 SEC14L4 IL27RA	5.76e-08	658	148	19	ctd:C016599
Drug	8a beta-indolizidine-1 alpha, 2 alpha, 8 beta-triol	NEU4 MAN2B1 FN1 BEAN1 CUBN NEU2 AGL	2.71e-06	94	148	7	CID000005363
Drug	rhamnose	NEU4 MAN2B1 FN1 THBS1 NEU2 CSF2RB MRC2 AGL PVR ELANE LTBP4 MUC5AC	3.86e-06	356	148	12	CID000000840
Drug	Rgd Peptide	RALGDS FN1 GIT1 DUSP2 RSPO4 THBS1 FBN1 IGFBP1 NID1 FBN3	3.87e-06	239	148	10	CID000104802
Drug	Mefexamide hydrochloride [3413-64-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A	STAB2 GRIK5 BAHD1 ADAM22 PAOX THBS1 PVR LTBP4 HCFC1	5.20e-06	194	148	9	2284_DN
Drug	Hydroflumethiazide [135-09-1]; Down 200; 12uM; MCF7; HT_HG-U133A	RALGDS CRIM1 IRF2BP1 BABAM2 BAHD1 LIG4 COCH LTBP4 IL27RA	5.42e-06	195	148	9	1687_DN
Drug	Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; MCF7; HT_HG-U133A	FLT4 STAB2 IRF2BP1 ZNF329 GRIK5 ADAM22 SNAPC3 LTBP4 HCFC1	5.89e-06	197	148	9	2228_DN
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A	HDAC6 IRF2BP1 GRIK5 SLC22A17 ADAM22 THBS1 PVR HCFC1 IL27RA	6.14e-06	198	148	9	6031_DN
Drug	Ioversol [87771-40-2]; Up 200; 5uM; MCF7; HT_HG-U133A	COL8A2 STAB2 MAP1A CASP9 NALF1 MRC2 PVR MMUT IL27RA	6.14e-06	198	148	9	5326_UP
Drug	zingerone	CASP9 LCAT LPL NOS2	6.16e-06	19	148	4	ctd:C013738
Drug	Saquinavir mesylate [149845-06-7]; Up 200; 5.2uM; MCF7; HT_HG-U133A	RALGDS CRYBG2 STAB2 FN1 IRF2BP1 ADAM22 YOD1 PVR HCFC1	6.66e-06	200	148	9	3549_UP
Drug	Grgesp	RALGDS FN1 PTCH1 THBS1 IGFBP1	7.60e-06	42	148	5	CID000492974
Drug	Leupeptin hydrochloride	FN1 BEAN1 KLK12 CASP9 CUBN STAB1 MRC2 ELANE EDEM1 KLKB1	1.37e-05	276	148	10	CID000003910
Drug	DB04780	FN1 KLK12 RSPO4 THBS1 NEU2 ARSL ASPA KLKB1	1.59e-05	170	148	8	CID005459389
Drug	troglitazone	VRK1 ABCA1 FN1 TRIP6 ADAM23 CASP9 RFC3 PTH1R COL18A1 FBN1 IGFBP1 CSF2RB LPL UCP3 RECQL4 ASPA TAF1 UQCRC1 LTBP4 KLKB1 NOS2 MMUT PRODH	1.61e-05	1329	148	23	ctd:C057693
Drug	chondroitin sulfate	NEU4 COL8A2 FN1 RSPO4 DDX11 COL18A1 THBS1 NEU2 ARSL LPL ELANE NID1	1.72e-05	413	148	12	CID000024766
Drug	polysialoganglioside	NEU4 FN1 CASP9 NEU2 PRODH	1.82e-05	50	148	5	CID006450319
Drug	AC1L1G2K	FN1 PTH1R COL18A1 ELANE NID1 KLKB1	1.83e-05	84	148	6	CID000003498
Drug	N-NBD-PE	NEU4 NEU2 ELANE	2.20e-05	9	148	3	CID000127398
Drug	desmosine	COL8A2 FN1 FBN1 ELANE FBN3	2.42e-05	53	148	5	CID000025435
Drug	Vancomycin	SOX4 FLNA VRK1 ABCA1 STAB2 FN1 CUBN STAB1 COL18A1 FBN1 IGFBP1 LPL PVR ASPA KBTBD11 NID1 MMUT PRODH	2.52e-05	906	148	18	ctd:D014640
Drug	LMWH	COL8A2 FLT4 FN1 DUSP2 POLR2B LAMA1 LAMA2 KLK12 LCAT COL18A1 THBS1 POLR3B LPL ELANE KLKB1	2.88e-05	663	148	15	CID000000772
Drug	Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; PC3; HT_HG-U133A	CRYBG2 DUSP2 ADAM22 THBS1 LPL PVR OSBPL7 NOTCH1	4.10e-05	194	148	8	6644_UP
Drug	Thioperamide maleate [106243-16-7]; Down 200; 9.8uM; MCF7; HT_HG-U133A	FLT4 IRF2BP1 CHML ADAM22 PAOX GPATCH3 PVR HCFC1	4.25e-05	195	148	8	5270_DN
Drug	Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; HL60; HG-U133A	SOX4 FN1 GRIK5 BAHD1 STAB1 TRIM66 SLC12A9 NOTCH1	4.25e-05	195	148	8	1371_DN
Drug	Lactobionic acid [96-82-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	FN1 IRF2BP1 SLC22A17 ADAM22 THBS1 PVR MUC5AC NOTCH1	4.40e-05	196	148	8	6605_DN
Drug	Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; PC3; HT_HG-U133A	RALGDS FLT4 GIT1 KLK12 PAOX TRIM66 OSBPL7 LTBP4	4.40e-05	196	148	8	4596_UP
Drug	Glibenclamide [10238-21-8]; Up 200; 8uM; HL60; HG-U133A	CRYBG2 STAB2 MAP1A GIT1 LAMA2 COL18A1 MRC2 LTBP4	4.40e-05	196	148	8	1546_UP
Drug	Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A	STAB2 DUSP2 ADAM22 TRIM66 THBS1 LTBP4 PRODH IL27RA	4.40e-05	196	148	8	2229_DN
Drug	wortmannin from Penicillium funiculosum; Down 200; 0.01uM; PC3; HT_HG-U133A	IRF2BP1 GRIK5 SLC22A17 PAOX YOD1 COL18A1 OSBPL3 LTBP4	4.40e-05	196	148	8	4467_DN
Drug	Indapamide [26807-65-8]; Down 200; 10.6uM; HL60; HT_HG-U133A	SOX4 FN1 ADAM23 BABAM2 PAOX SLC12A9 OSBPL3 HCFC1	4.40e-05	196	148	8	2361_DN
Drug	Metronidazole [443-48-1]; Up 200; 23.4uM; MCF7; HT_HG-U133A	IRF2BP1 CASP9 PTCH1 PAOX MRC2 PVR LTBP4 PRODH	4.57e-05	197	148	8	1503_UP
Drug	Danazol [17230-88-5]; Up 200; 11.8uM; HL60; HG-U133A	COL8A2 CRYBG2 MAP1A GIT1 LAMA2 CIITA MRC2 PVR	4.57e-05	197	148	8	2038_UP
Drug	Carbimazole [22232-54-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A	GIT1 PAOX LIG4 THBS1 GPATCH3 PVR KBTBD11 TAF1	4.57e-05	197	148	8	3299_DN
Drug	Nicergoline; Up 200; 8.2uM; PC3; HT_HG-U133A	IRF2BP1 ADAM23 ADAM22 STAB1 CIITA MRC2 NXPH3 PRODH	4.57e-05	197	148	8	5775_UP
Drug	Droperidol [548-73-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A	SOX4 RALGDS HDAC6 ZNF329 LIG4 COCH TAF1 SNAPC3	4.73e-05	198	148	8	5690_DN
Drug	Merbromin [129-16-8]; Up 200; 5uM; HL60; HT_HG-U133A	SOX4 ABCA1 PAOX LIG4 GPATCH3 MRC2 WDR1 IL27RA	4.73e-05	198	148	8	2577_UP
Drug	Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; HL60; HG-U133A	CRYBG2 MAP1A GIT1 LAMA2 COL18A1 MRC2 LTBP4 NXPH3	4.73e-05	198	148	8	2042_UP
Drug	Ampyrone [83-07-8]; Up 200; 19.6uM; HL60; HG-U133A	COL8A2 CRYBG2 STAB2 MAP1A GIT1 LAMA2 COL18A1 CIITA	4.73e-05	198	148	8	1402_UP
Drug	Acetazolamide [59-66-5]; Up 200; 18uM; MCF7; HT_HG-U133A	CRYBG2 STAB2 IRF2BP1 MAP1A CHML ADAM22 KBTBD11 LTBP4	4.90e-05	199	148	8	7461_UP
Drug	Vancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; MCF7; HT_HG-U133A	COL8A2 CRYBG2 STAB2 HDAC6 LAMA2 GRIK5 PAOX OSBPL3	4.90e-05	199	148	8	4423_UP
Drug	Sulmazole [73384-60-8]; Up 200; 14uM; HL60; HT_HG-U133A	SOX4 FN1 IRF2BP1 MAP1A UCP3 PVR WDR1 NXPH3	4.90e-05	199	148	8	2153_UP
Drug	Ciprofibrate [52214-84-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A	CRYBG2 ABCA1 IRF2BP1 GPX5 GRIK5 ADAM22 MRC2 NXPH3	4.90e-05	199	148	8	3561_UP
Drug	Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; HL60; HT_HG-U133A	SOX4 FN1 DUSP2 BABAM2 TRIM66 THBS1 OSBPL3 SNAPC3	5.08e-05	200	148	8	1871_DN
Drug	nordihydroguaiaretic acid; Up 200; 1uM; PC3; HT_HG-U133A	COL8A2 CRYBG2 ADAM22 STAB1 CSF2RB MRC2 MUC5AC HCFC1	5.08e-05	200	148	8	4447_UP
Drug	AC1O0B8G	RALGDS LAMA1 LAMA2 CASP9 PTCH1 TRIP4 THBS1 RECQL4 NOS2	5.62e-05	262	148	9	CID000091605
Drug	6-bromocyclohex-4-ene-1,2,3-triol	ERF MAN2B1 FN1 AGL	6.06e-05	33	148	4	CID000122062
Drug	isodesmosine	COL8A2 FN1 FBN1 ELANE	6.06e-05	33	148	4	CID000013811
Drug	Rgds Peptide	RALGDS FN1 DUSP2 THBS1 ELANE NID1	6.81e-05	106	148	6	CID000107775
Drug	Phe-glu	FN1 ELANE KLKB1	7.34e-05	13	148	3	CID000151134
Drug	tetrahydrocurcumin	LCAT LPL NOS2	7.34e-05	13	148	3	ctd:C096277
Drug	Gdrgdsp	RALGDS FN1 DUSP2 RSPO4 THBS1 NID1	7.96e-05	109	148	6	CID000115346
Drug	AC1L9KAW	ABCA1 FN1 BEAN1 POLR3B PVR TAF1 UQCRC1	1.01e-04	164	148	7	CID000446965
Drug	Losartan	FLT4 FN1 CASP9 CUBN PTH1R UCP3 NOS2	1.05e-04	165	148	7	ctd:D019808
Drug	C12063	NEU4 ERF MAN2B1 FN1 CASP9 CUBN ZP1 NEU2 AGL LPL EDEM1	1.19e-04	429	148	11	CID005282055
Drug	clopidol	ARSL PITX1	1.25e-04	3	148	2	CID000018087
Drug	NSC-343257	NEU4 ABCA1 ERF FN1 STAB1 NEU2 LPL MMUT	1.27e-04	228	148	8	CID000004242
Drug	25-hydroxycholesterol	ABCA1 CASP9 LPL NOS2	1.31e-04	40	148	4	ctd:C007997
Drug	Cycloheximide [66-81-9]; Down 200; 14.2uM; HL60; HT_HG-U133A	SOX4 RALGDS FN1 ADAM23 DUSP2 NETO2 KBTBD11	1.31e-04	171	148	7	2723_DN
Drug	CPD-7389	BEAN1 DUSP2 NOS2	1.42e-04	16	148	3	CID000067111
Drug	sivelestat	PAOX ELANE KLKB1 NOS2	1.44e-04	41	148	4	CID000107706
Drug	YIGSR	RALGDS FN1 LAMA1 LAMA2 NID1	1.66e-04	79	148	5	CID000123977
Drug	Parthenolide [20554-84-1]; Down 200; 16.2uM; HL60; HG-U133A	SOX4 FN1 TRIP6 CD300A PTCH1 RFC3 AGL	1.68e-04	178	148	7	1736_DN
Drug	Bz alpha GalNAc	NEU4 FN1 NEU2 MUC5AC	1.74e-04	43	148	4	CID000122253
Drug	losartan	COL8A2 FN1 MMP27 PTH1R COL18A1 THBS1 FBN1 LPL MOV10L1 NOS2	1.89e-04	378	148	10	CID000003961
Drug	Grgds	FLNA RALGDS FN1 RSPO4 THBS1	2.09e-04	83	148	5	CID000123811
Drug	AC1NRATE	ERF MAN2B1 FN1 AGL LPL	2.09e-04	83	148	5	CID005288086
Drug	2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine	FN1 LAMA1 LAMA2 THBS1 FBN1	2.09e-04	83	148	5	CID011968896
Drug	Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; PC3; HT_HG-U133A	CHD7 YOD1 LIG4 THBS1 FBN1 PITX1 NOTCH1	2.27e-04	187	148	7	7402_DN
Drug	tropine	ABCA1 PTCH1 ELANE	2.42e-04	19	148	3	CID000008424
Drug	Lansoprazole [103577-45-3]; Down 200; 10.8uM; HL60; HT_HG-U133A	FN1 DUSP2 DENND1C PTCH1 BABAM2 BAHD1 PVR	2.43e-04	189	148	7	2967_DN
Drug	NSC-335754	ELANE NOS2	2.50e-04	4	148	2	CID000333563
Drug	robustaflavone	ELANE NOS2	2.50e-04	4	148	2	CID005281694
Drug	15d-PGJ2; Down 200; 10uM; HL60; HT_HG-U133A	SOX4 FN1 CRIM1 CHD7 PTCH1 KBTBD11 HCFC1	2.51e-04	190	148	7	1172_DN
Drug	Naftopidil dihydrochloride [57149-08-3]; Up 200; 8.6uM; HL60; HT_HG-U133A	MYF5 CRYBG2 FN1 GIT1 GRIK5 ADAM22 THBS1	2.51e-04	190	148	7	2911_UP
Drug	5707885; Down 200; 50uM; PC3; HT_HG-U133A	SOX4 ABCA1 DUSP2 THBS1 SLC12A9 PVR LTBP4	2.59e-04	191	148	7	6390_DN
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; PC3; HT_HG-U133A	GRIK5 SLC22A17 LIG4 PVR PITX1 WDR1 NXPH3	2.59e-04	191	148	7	4298_DN
Drug	Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A	ABCA1 DUSP2 SLC22A17 PAOX SCUBE2 PVR MMUT	2.59e-04	191	148	7	3890_DN
Drug	Isoetharine mesylate salt [7279-75-6]; Up 200; 12uM; PC3; HT_HG-U133A	ABCA1 IRF2BP1 MAP1A PAOX YOD1 GPATCH3 HCFC1	2.67e-04	192	148	7	5812_UP
Drug	sulfate	NEU4 MAN2B1 FN1 LAMA1 LAMA2 RSPO4 COL18A1 THBS1 NEU2 ARSL TLL1 LPL ELANE NID1 TAF1 MUC5AC KLKB1 NOS2 IL27RA ADSS1	2.72e-04	1292	148	20	CID000001117
Drug	Ethynodiol diacetate [297-76-7]; Up 200; 10.4uM; PC3; HT_HG-U133A	HDAC6 DUSP2 ADAM22 PAOX MRC2 PVR MUC5AC	2.76e-04	193	148	7	6678_UP
Drug	Oxalamine citrate salt [1949-20-8]; Up 200; 9.2uM; MCF7; HT_HG-U133A	CRYBG2 FN1 IRF2BP1 ZNF423 THBS1 LTBP4 MUC5AC	2.76e-04	193	148	7	3344_UP
Drug	Novobiocin sodium salt [1476-53-5]; Up 200; 6.4uM; PC3; HT_HG-U133A	CRYBG2 LCAT THBS1 UCP3 LTBP4 MUC5AC KLKB1	2.76e-04	193	148	7	4569_UP
Drug	Morph	MYF5 KREMEN1 POLR2B	2.83e-04	20	148	3	CID000115379
Drug	Omeprazole [73590-58-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A	IRF2BP1 CHML ADAM22 PVR TAF1 PRODH IL27RA	2.84e-04	194	148	7	2828_UP
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A	ADAM22 PAOX YOD1 NALF1 PVR LTBP4 HCFC1	2.84e-04	194	148	7	4763_DN
Drug	Viomycin sulfate [37883-00-4]; Down 200; 5.2uM; MCF7; HT_HG-U133A	FLT4 IRF2BP1 LIG4 SCUBE2 GPATCH3 PITX1 TAF1	2.84e-04	194	148	7	7036_DN
Drug	Dehydroisoandosterone 3-acetate [853-23-6]; Up 200; 12.2uM; PC3; HT_HG-U133A	FN1 DUSP2 CHML ADAM22 TLL1 UCP3 PVR	2.84e-04	194	148	7	6673_UP
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; HL60; HT_HG-U133A	SOX4 FN1 DUSP2 CHML BABAM2 OSBPL3 KBTBD11	2.84e-04	194	148	7	6178_DN
Drug	S-(+)-ibuprofen [51146-56-6]; Up 200; 19.4uM; PC3; HT_HG-U133A	ZNF423 GRIK5 LCAT CUBN PTCH1 ADAM22 PITX1	2.84e-04	194	148	7	6712_UP
Drug	Cefoperazone dihydrate; Down 200; 5.8uM; MCF7; HT_HG-U133A	ABCA1 FN1 IRF2BP1 GIT1 PAOX SLC12A9 PVR	2.93e-04	195	148	7	5424_DN
Drug	Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; MCF7; HT_HG-U133A	FLT4 DENND1C ADAM22 PVR PITX1 LTBP4 HCFC1	2.93e-04	195	148	7	7219_UP
Drug	Flunisolide [3385-03-3]; Up 200; 9.2uM; PC3; HT_HG-U133A	ADAM23 DUSP2 KLK12 ADAM22 CSF2RB PVR NOS2	2.93e-04	195	148	7	3747_UP
Drug	Phenylpropanolamine hydrochloride [154-41-6]; Up 200; 21.4uM; MCF7; HT_HG-U133A	FN1 DENND1C CHML THBS1 LPL PITX1 ELANE	2.93e-04	195	148	7	3217_UP
Drug	Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	CRYBG2 ZNF423 DENND1C STAB1 FBN1 LPL PVR	2.93e-04	195	148	7	5261_UP
Drug	ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A	CRYBG2 BABAM2 SLC22A17 PAOX YOD1 MUC5AC HCFC1	2.93e-04	195	148	7	5969_DN
Drug	Sulfadimethoxine [122-11-2]; Down 200; 12.8uM; HL60; HT_HG-U133A	FLT4 IRF2BP1 ADAM23 PTCH1 CHML SLC12A9 PVR	2.93e-04	195	148	7	2578_DN
Drug	Fluspirilen [1841-19-6]; Down 200; 8.4uM; MCF7; HT_HG-U133A	FLT4 HDAC6 CRIM1 DUSP2 PAOX HCFC1 IL27RA	2.93e-04	195	148	7	5008_DN
Drug	Flumethasone [2135-17-3]; Down 200; 9.8uM; MCF7; HT_HG-U133A	COL8A2 ABCA1 SLC22A17 TRIM66 PVR LTBP4 IL27RA	2.93e-04	195	148	7	4734_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	FLT4 FN1 IRF2BP1 BABAM2 SLC22A17 SCUBE2 MRC2	2.93e-04	195	148	7	5241_DN
Disease	cholangiocarcinoma (is_marker_for)	HDAC6 THBS1 OSBPL7 MUC5AC NOS2 NOTCH1	7.53e-07	64	145	6	DOID:4947 (is_marker_for)
Disease	colorectal health	PAMR1 GRIK5 BABAM2 DDX11 LIG4 NALF1 SCUBE2	6.40e-05	201	145	7	EFO_0008460
Disease	connective tissue disease (implicated_via_orthology)	FBN1 FBN3	7.17e-05	3	145	2	DOID:65 (implicated_via_orthology)
Disease	Familial thoracic aortic aneurysm and aortic dissection	FLNA COL18A1 FBN1 NOTCH1	1.36e-04	53	145	4	C4707243
Disease	cancer aggressiveness measurement, Gleason score measurement, prostate carcinoma	NAALADL2 KLKB1	2.38e-04	5	145	2	EFO_0001663, EFO_0006999, EFO_0007000
Disease	level of lipoprotein lipase in blood serum	LPL KLKB1	2.38e-04	5	145	2	OBA_2042223
Disease	diabetic angiopathy (implicated_via_orthology)	FN1 NOS2	3.55e-04	6	145	2	DOID:11713 (implicated_via_orthology)
Disease	Cholangitis, Sclerosing	MST1 NOS2	3.55e-04	6	145	2	C0008313
Disease	cholesteryl esters to total lipids in large LDL percentage	ABCA1 LCAT LPL	4.72e-04	31	145	3	EFO_0022249
Disease	toxic shock syndrome (implicated_via_orthology)	ELANE NOS2	4.96e-04	7	145	2	DOID:14115 (implicated_via_orthology)
Disease	Acute lymphocytic leukemia	LIG4 NOTCH1	4.96e-04	7	145	2	C0023449
Disease	primary dental caries	CUBN OSBPL3 TLL1	6.22e-04	34	145	3	EFO_0600095
Disease	Profound Mental Retardation	RALGDS VRK1 LAMA1 COL18A1 POLR3B	6.34e-04	139	145	5	C0020796
Disease	Mental Retardation, Psychosocial	RALGDS VRK1 LAMA1 COL18A1 POLR3B	6.34e-04	139	145	5	C0025363
Disease	Mental deficiency	RALGDS VRK1 LAMA1 COL18A1 POLR3B	6.34e-04	139	145	5	C0917816
Disease	Primary sclerosing cholangitis	MST1 NOS2	6.59e-04	8	145	2	C0566602
Disease	thrombin generation potential measurement, thrombomodulin measurement	RALGDS KLKB1	6.59e-04	8	145	2	EFO_0005538, EFO_0007774
Disease	mitral valve prolapse (is_implicated_in)	FLNA FBN1	8.44e-04	9	145	2	DOID:988 (is_implicated_in)
Disease	Marfan Syndrome, Type I	FBN1 NOS2	8.44e-04	9	145	2	C4721845
Disease	gamma-glutamylisoleucine measurement	LAMA2 CARNS1	8.44e-04	9	145	2	EFO_0021139
Disease	nasopharyngeal neoplasm	FLT4 HENMT1 LIG4 NALF1 CIITA	9.21e-04	151	145	5	EFO_0004252
Disease	hypertension (biomarker_via_orthology)	HDAC6 FN1 CASP9 FBN1 UCP3 NOS2	9.28e-04	227	145	6	DOID:10763 (biomarker_via_orthology)
Disease	Hypercholesterolemia	ABCA1 LCAT LPL	9.33e-04	39	145	3	C0020443
Disease	Prostatic Neoplasms	STAB2 HDAC6 ERF CASP9 UNC13D RFX6 CHD7 LPL UCP3 PVR	9.71e-04	616	145	10	C0033578
Disease	Malignant neoplasm of prostate	STAB2 HDAC6 ERF CASP9 UNC13D RFX6 CHD7 LPL UCP3 PVR	9.71e-04	616	145	10	C0376358
Disease	eosinophil count	FLNA NEU4 UNC13D RFX6 CHD7 GRIK5 CILP2 CSF2RB CIITA WDR6 LPL ZNF319 FER1L5 LTBP4 MUC5AC NOS2 NOTCH1	1.05e-03	1488	145	17	EFO_0004842
Disease	fish oil supplement exposure measurement, triglyceride measurement	MAP1A LPL	1.05e-03	10	145	2	EFO_0004530, EFO_0600007
Disease	1,7-dimethylurate measurement	GRIK5 NAALADL2	1.05e-03	10	145	2	EFO_0021512
Disease	vital capacity	CAND2 FN1 CRIM1 POLR2B LAMA2 UNC13D CHD7 PTCH1 TRIM66 THBS1 MRC2 CARNS1 LTBP4 FBN3 NPAS4	1.16e-03	1236	145	15	EFO_0004312
Disease	cortical thickness	CRIM1 NUP210L ZNF423 FAT3 LAMA1 LAMA2 CHD7 PTCH1 STAB1 COL18A1 THBS1 FBN1 COCH NALF1	1.21e-03	1113	145	14	EFO_0004840
Disease	Retinal Detachment	CASP9 COL18A1	1.28e-03	11	145	2	C0035305
Disease	Marfan Syndrome	FBN1 NOS2	1.28e-03	11	145	2	C0024796
Disease	Schizophrenia	CACNA1F ABCA1 KREMEN1 LAMA1 LAMA2 GRIK5 CSMD2 THBS1 CSF2RB LPL NPAS4 PRODH	1.43e-03	883	145	12	C0036341
Disease	coronary artery disease (is_implicated_in)	ABCA1 CUBN TLL1 LPL	1.52e-03	100	145	4	DOID:3393 (is_implicated_in)
Disease	craniosynostosis (is_implicated_in)	FLNA ERF	1.53e-03	12	145	2	DOID:2340 (is_implicated_in)
Disease	retinopathy of prematurity (biomarker_via_orthology)	NOS2 NOTCH1	1.53e-03	12	145	2	DOID:13025 (biomarker_via_orthology)
Disease	focal segmental glomerulosclerosis (biomarker_via_orthology)	CASP9 LPL	1.53e-03	12	145	2	DOID:1312 (biomarker_via_orthology)
Disease	familial hyperlipidemia (implicated_via_orthology)	LCAT LPL	1.53e-03	12	145	2	DOID:1168 (implicated_via_orthology)
Disease	alkaline phosphatase measurement	RALGDS MAP1A TRIP6 GRIK5 PTCH1 BABAM2 CILP2 SLC12A9 CASKIN1 LPL RECQL4 EDEM1 NOTCH1	1.54e-03	1015	145	13	EFO_0004533
Disease	pancreatic cancer (is_marker_for)	PTCH1 THBS1 MUC5AC NOS2	1.58e-03	101	145	4	DOID:1793 (is_marker_for)
Disease	type 2 diabetes mellitus (is_implicated_in)	ABCA1 CASP9 LPL UCP3 NOS2	1.60e-03	171	145	5	DOID:9352 (is_implicated_in)
Disease	gamma-glutamylleucine measurement	NALF1 CARNS1	1.81e-03	13	145	2	EFO_0021140
Disease	interleukin 6 receptor subunit alpha measurement	NUP210L OTUD7B	1.81e-03	13	145	2	EFO_0008187
Disease	pleurisy (implicated_via_orthology)	ELANE NOS2	1.81e-03	13	145	2	DOID:10247 (implicated_via_orthology)
Disease	Hyperlipoproteinemia Type IIb	ABCA1 LPL	1.81e-03	13	145	2	C1704417
Disease	metabolite measurement	THEM5 CASP9 BABAM2 ADAM22 STAB1 PAOX LPL KLKB1 PRODH	1.86e-03	560	145	9	EFO_0004725
Disease	Glioblastoma Multiforme	FN1 GUCY2F LTBP4 NOTCH1	2.23e-03	111	145	4	C1621958
Disease	nervous system disorder	CASP9 NOTCH1 PRODH	2.27e-03	53	145	3	C0027765
Disease	stroke outcome severity measurement	ADAM23 GRIK5 PTCH1 NAALADL2	2.46e-03	114	145	4	EFO_0009603
Disease	behavior	ZNF423 PTCH1 LPL	2.53e-03	55	145	3	GO_0007610
Disease	free cholesterol to total lipids in very large HDL percentage	ABCA1 LCAT LPL	2.53e-03	55	145	3	EFO_0022288
Disease	cholesterol to total lipids in large LDL percentage	ABCA1 LCAT LPL	2.66e-03	56	145	3	EFO_0022235
Disease	Hyperlipoproteinemia Type IIa	ABCA1 LPL	2.75e-03	16	145	2	C0745103
Disease	Schizoaffective disorder-bipolar type	STAB2 PTCH1	2.75e-03	16	145	2	EFO_0009965
Disease	free cholesterol in medium HDL measurement	ABCA1 LCAT LPL	2.94e-03	58	145	3	EFO_0022267
Disease	waist-hip ratio	ABCA1 CAND2 FN1 ADAM23 ZNF423 CEP192 STAB1 TRIM66 COL18A1 SCUBE2 CIITA LPL GPCPD1 NID1	2.94e-03	1226	145	14	EFO_0004343
Disease	cholesterol in medium HDL measurement	ABCA1 LCAT LPL	3.09e-03	59	145	3	EFO_0021903
Disease	Sjogren's syndrome (implicated_via_orthology)	MUC19 THBS1	3.11e-03	17	145	2	DOID:12894 (implicated_via_orthology)
Disease	heart disease (biomarker_via_orthology)	CASP9 THBS1	3.11e-03	17	145	2	DOID:114 (biomarker_via_orthology)
Disease	otitis media (biomarker_via_orthology)	MUC5AC NOS2	3.11e-03	17	145	2	DOID:10754 (biomarker_via_orthology)
Disease	free cholesterol to total lipids in medium HDL percentage	ABCA1 LCAT LPL	3.24e-03	60	145	3	EFO_0022282
Disease	sexual dimorphism measurement	ABCA1 CRIM1 GPX5 LCAT PTCH1 FBN1 GPATCH3 CASKIN1 LPL PITX1 ZSCAN2 CARNS1 NPAS4	3.25e-03	1106	145	13	EFO_0021796
Disease	free cholesterol in HDL measurement	ABCA1 LCAT LPL	3.40e-03	61	145	3	EFO_0022264
Disease	Idiopathic hypogonadotropic hypogonadism	CHD7 POLR3B	3.48e-03	18	145	2	C0342384
Disease	Hypercholesterolemia, Familial	ABCA1 LPL	3.48e-03	18	145	2	C0020445
Disease	hip bone mineral density	CRIM1 PAMR1 PTCH1 COL18A1	3.52e-03	126	145	4	EFO_0007702
Disease	pulse pressure measurement	FN1 CRIM1 ZNF423 FAT3 UNC13D SLC22A17 TRIM66 CILP2 FBN1 MRC2 LPL OSBPL7 WDR1 FER1L5 HCFC1	3.62e-03	1392	145	15	EFO_0005763
Disease	total lipids in HDL measurement	ABCA1 LCAT LPL	3.72e-03	63	145	3	EFO_0022307
Disease	osteochondrodysplasia (is_implicated_in)	FLNA PTH1R	3.88e-03	19	145	2	DOID:2256 (is_implicated_in)
Disease	glomerulonephritis (is_marker_for)	FN1 KLKB1	3.88e-03	19	145	2	DOID:2921 (is_marker_for)
Disease	Dyschondroplasias	FLNA PTH1R	3.88e-03	19	145	2	C0013366
Disease	Omenn Syndrome	CHD7 LIG4	3.88e-03	19	145	2	C2700553
Disease	response to heparin, antibody measurement	GRIK5 NAALADL2	4.30e-03	20	145	2	EFO_0004556, EFO_0006816
Disease	central corneal thickness	COL8A2 CRIM1 BABAM2 MST1 FBN1 INCA1	4.34e-03	309	145	6	EFO_0005213
Disease	gastric ulcer (biomarker_via_orthology)	COL18A1 MUC5AC	4.74e-03	21	145	2	DOID:10808 (biomarker_via_orthology)
Disease	nose morphology measurement, mouth morphology measurement	RFC3 FBN3	4.74e-03	21	145	2	EFO_0007843, EFO_0007955

Protein segments in the cluster

Peptide	Gene	Start	Entry
YPFIDVGLAGGAVPQ	ERF	116	P50548
PTKLFEPTECGNGYV	ADAM23	496	O75077
TPVFQPEGAGACYGR	ARSL	481	P51690
IEQGSCGDPGIPAYG	CSMD2	516	Q7Z408
PCEDPGIPQYGSRIG	CSMD3	1181	Q7Z407
PGDTVVFQCDPGYEL	CSMD3	1546	Q7Z407
QDTYGAEPAGPDGIL	CIITA	346	P33076
CFRYPTPGEAPGVVG	ABCA1	81	O95477
VDLGYVEDGTPCGPQ	ADAM22	646	Q9P0K1
LCQGLGIDGPSYPVA	CARNS1	806	A5YM72
LVVYGADPGSPDVNG	GIT1	186	Q9Y2X7
DYRTGPCFGQVGPEG	FBN3	181	Q75N90
EYRTLCPGGEGFQPN	FBN3	1541	Q75N90
GGYRDALVCSPGQPV	DENND1C	341	Q8IV53
LEGLGECGYPENPVN	CHD7	21	Q9P2D1
LFPLYGQGEIPQGFC	CHML	376	P26374
NPCFLYLRCGPDGGE	PAAT	71	Q9H8K7
PEETVYLAAEGQPGG	RFX6	41	Q8HWS3
VGYPPECLDLSNGDT	YOD1	91	Q5VVQ6
LLEVGGLEFPGCPFN	NOS2	356	P35228
FGGIYLPLEVPASQC	OTUD7B	331	Q6GQQ9
TPQECKGSFLVYPDG	CACNA1F	1036	O60840
GDIPPGCAAYGFVCD	HCFC1	76	P51610
CGVPDVGQYGYTLPG	MMP27	91	Q9H306
GFAYVLPQPVEGEVG	CASKIN1	831	Q8WXD9
IGGGGYFPEASPQQC	ITLN1	266	Q8WWA0
YDGSCIPSPEGEFGD	MYF5	16	P13349
DQVGGYSCTCPPGFV	NOTCH1	1246	P46531
QEGAAELEGGPYSPL	MAP1A	1891	P78559
CGEGVADPSYPVVPE	MOV10L1	1186	Q9BXT6
LNCSVLPGDLYPGGA	NMUR1	6	Q9HB89
PCGQDGIPGVYTYIC	KLK12	221	Q9UKR0
PIPFCGDYIGLQGNP	MYO1A	866	Q9UBC5
GGPVEILPYLFLGSC	DUSP2	171	Q05923
QGTYLADIPASPCGE	GPATCH3	261	Q96I76
GSPEIRGDPNCQIYF	IGFBP1	241	P08833
DIYPNGGTFQPGCNI	LPL	231	P06858
SGTVYQPGEVREGPC	MUC19	781	Q7Z5P9
GYQGDGFRCVPGEVE	NID1	831	P14543
PTQEDGYCVLIGPAA	COL18A1	436	P39060
AGPLQCYGVGPLGDL	IL27RA	36	Q6UWB1
DGEPQQPGGCTYVDV	MRC2	1211	Q9UBG0
PGLGPECFTANGADY	KREMEN1	26	Q96MU8
RCAEGYFGQPSVPGG	LAMA2	846	P24043
GTGELYVPCEPQGLL	KRT82	476	Q9NSB4
GCPEGARAIPTYQEG	MUC5AC	5356	P98088
CGVVPGGVVCFFPSY	DDX11	696	Q96FC9
GPAPEGGLVFACLYE	NEU4	426	Q8WWR8
DQCPAVAGYGPIEQL	UQCRC1	451	P31930
YIGDGGNDVCPVTFL	PHOSPHO2	176	Q8TCD6
EVGCGTGANFKFYPP	METTL7A	76	Q9H8H3
GTGPDGSPLFGCLYE	NEU2	341	Q9Y3R4
CLLYSEGPEGPITAN	NPAS4	296	Q8IUM7
QQPECGGILTGPYGS	CUBN	586	O60494
GEPPAGAENVGYCTQ	HENMT1	211	Q5T8I9
LQQVGDYCFLPGLGP	CSF2RB	816	P32927
GYFLEPKTIGGPCQV	GPCPD1	71	Q9NPB8
GGYIVQNPGPDTYCV	LIG4	686	P49917
HIPAFPGGGCLIDYV	BABAM2	236	Q9NXR7
EDRLEQYEGPGFCGP	FCGBP	1866	Q9Y6R7
GLVPPAQYFQGCLLD	FCGBP	2281	Q9Y6R7
PEDRLEQYEGPGFCG	FCGBP	3066	Q9Y6R7
LEQYEGPGFCGPLSS	FCGBP	4271	Q9Y6R7
PAVDTSGVQCYGPGI	FLNA	1251	P21333
YGGNSNGEPCVLPFT	FN1	351	P02751
CPYGSGIIVGPDDSA	FBN1	2111	P35555
FPGAVYGTDGCPVSV	CASP9	246	P55211
NPATGIFTCPVGGVY	COL8A2	606	P25067
SGFIGPTNPGYCEAA	GUCY2F	121	P51841
GEPRAVVYEAPGFQG	CRYBG2	1166	Q8N1P7
VACQGVISYDFPVGG	FAT3	581	Q8TDW7
PSICHAPGGEYFVEG	CRIM1	676	Q9NZV1
PADYNGLCVGPELTA	BAHD1	361	Q8TBE0
GNICVYCPGGPDSDF	ELP3	106	Q9H9T3
GREACNEGEGDPPLY	EDEM1	406	Q92611
YGCILPYSDEDGGPQ	RALGDS	176	Q12967
GARAGGYETCPTVQP	MAN2B1	46	O00754
GSEGFREICPAGPGY	LTBP4	451	Q8N2S1
TVCGFSGGLPYPAVA	CEP192	1286	Q8TEP8
PCHSKIYPGVDFGGE	KLKB1	291	P03952
AGLPAPGVEVYCLYG	LCAT	326	P04180
GGCASGLYPDAFAPV	ELANE	221	P08246
GDPLGGCQVSPEGYA	HDAC6	746	Q9UBN7
LAPVGACEGDYGGPL	MST1	651	P26927
LVEDGLYGAPEPNGS	GRIK5	466	Q16478
PYGLVVLGFPCNQFG	GPX5	91	O75715
PGYEECVGPGATQLY	BEAN1	146	Q3B7T3
LTAPVYEQAVDGGPG	CAND2	781	O75155
PGGCPLEEFSVYGNI	COCH	51	O43405
GLCQPGEYSADGFAP	SCUBE2	696	Q9NQ36
PPEVIQLYDSGGLCG	SEC14L4	76	Q9UDX3
KAQGPAGEVYCPSGD	IRF2BP1	536	Q8IU81
GSKPFNPVLGETYEC	OSBPL3	601	Q9H4L5
LPNCTIYVVEPGFLG	NUP210L	346	Q5VU65
RGGGCYFGPDVTQQL	PPEF2	461	O14830
EERNCSDPGGPVNGY	PAMR1	276	Q6UXH9
AGCKPFNPVLGETYE	OSBPL7	551	Q9BZF2
QCGDFPHLLVYGPSG	RFC3	31	P40938
GEEGCGFPSTNEYPD	INCA1	151	Q0VD86
APFGEYTVLPGLDCT	PAOX	206	Q6QHF9
LYLVICGQDDGPPGS	NXPH3	16	O95157
QVPGFLGDSVTLPCY	PVR	36	P15151
CKGGYVPQFSGLVQP	PITX1	156	P78337
PLGLYEEEGAGCSPD	SOX4	321	Q06945
CPGVFLPGKQDVYLG	SPATA6L	16	Q8N4H0
CTGLGIPPQNIGDVY	ADSS1	281	Q8N142
HDCPPGYFGIRGQEV	RSPO4	71	Q2I0M5
GLGRFCGSGPPEEIY	TLL1	961	O43897
CGSGPPEEIYSIGDS	TLL1	966	O43897
QPVGGGGSPSDFYLC	SLC22A17	326	Q8WUG5
IEGVYSGFLPCFGPS	FER1L5	421	A0AVI2
GIGSPCYPAQVYGQD	RECQL4	1166	O94761
PTGCGEGFSYVKIPN	TAF1	956	P21675
GVHCEQCLPGFYGEP	LAMA1	766	P25391
PESAIQGGELGAPEY	FAM90A26	316	D6RGX4
CDQISFPLGQAGYPV	PRODH	531	O43272
GLCPGYPETDHGLFE	PTCH1	1396	Q13635
ECPLDPGGYFIINGS	POLR2B	176	P30876
YLGGILNPIPDCQFE	NETO2	166	Q8NC67
LDVQPKCVAVGPGGY	WDR1	406	O75083
VSGSGGCNFPEYELP	SNAPC3	21	Q92966
APCVLYPGTEPGAAG	KBTBD11	6	O94819
PGFGAVYGEPDLVLE	KBTBD11	131	O94819
PLGGDCTVYPVFVNE	ASPA	271	P45381
GPVGGSLSVQCPYEK	CD300A	26	Q9UGN4
LPEDCGQPGSGPAYL	CILP2	396	Q8IUL8
GQPGSGPAYLDVGLC	CILP2	401	Q8IUL8
TEGPCSPYNGLVAGL	UCP3	71	P55916
PPGYSGNGIQCTDVD	THBS1	576	P07996
SEQCYQAPGGPEDRG	TRIP6	51	Q15654
GLQGTYLGEKPYECP	ZSCAN2	211	Q7Z7L9
VGFEDSYGQEPTLGP	ZP1	576	P60852
GAPGEVVAVPCPDYI	PTH1R	121	Q03431
VCLFQPGSYLEGPPG	THEM5	141	Q8N1Q8
GEYVEPQDCRVSPGG	ZSCAN25	256	Q6NSZ9
GGPGYVDVCGLFLLQ	SLC12A9	736	Q9BXP2
GASPYPGVQINEEFC	FLT4	1111	P35916
LGFAGDGYQCSPIDP	STAB1	936	Q9NY15
EGYRGDGQVCLPVDP	STAB2	266	Q8WWQ8
EDGVGGPYTIFVPNN	STAB2	546	Q8WWQ8
CPLDPGGYFIVKGVE	POLR3B	161	Q9NW08
QSYCLLEAAPGPEGF	WDR6	391	Q9NNW5
LPIGQGGFGCIYLAD	VRK1	41	Q99986
DGYVCYEPGPQALGG	ZFP42	51	Q96MM3
GCAVYGILLQPDPGL	ZNF319	46	Q9P2F9
CGSPAYAAPEVLQGI	TSSK1B	176	Q9BXA7
VEFPNDYPSGCLLGC	TRIP4	496	Q15650
EGGTGLPYPCQFCDK	ZNF423	131	Q2M1K9
NYFLGDDGEPPCGLC	PIGG	596	Q5H8A4
SPGVNGGPGDFTLYC	TRIM66	51	O15016
KPGTQEAICEYPGFG	ZNF329	56	Q86UD4
FSDPYCLLGIEQGVG	UNC13D	131	Q70J99
QAGPPELNYGATGEC	ZNF449	166	Q6P9G9
ATGECQNFLDPGYPL	ZNF449	176	Q6P9G9
LNGDYKGTVPVPEGC	TRIM56	536	Q9BRZ2
YGGEPVGSFVQPCLR	AGL	596	P35573
CPFILPDNDEVIYGG	NALF1	341	B1AL88
GFGGVLLYIDPCDLP	NAALADL2	321	Q58DX5
CGGVIPPQDYEFLFE	MMUT	701	P22033
GQGPATYGPFCAERL	MYO7B	1156	Q6PIF6
PDGQYDPETGTGLLC	MYOM3	1161	Q5VTT5